<SEC-DOCUMENT>0001140361-25-046175.txt : 20251219
<SEC-HEADER>0001140361-25-046175.hdr.sgml : 20251219
<ACCEPTANCE-DATETIME>20251219142922
ACCESSION NUMBER:		0001140361-25-046175
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20251219
DATE AS OF CHANGE:		20251219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		251586959

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20061656_424b2.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <table cellspacing="0" cellpadding="0" id="z937fa4c549a2438ba40146fa8afd364b" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify;"><img width="57" height="48" src="image0.jpg"></div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: right; font-size: 8pt; font-weight: bold;">Filed Pursuant to Rule 424(b)(2)</div>
              <div style="text-align: right; font-size: 8pt; font-weight: bold;">Registration Statement No. 333-283969</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="2" border="0" id="z0dbd00fe5412441ab4739e08d301f6d1" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: top; background-color: #000000;"><br>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; font-size: 8.5pt;">Pricing Supplement dated December 18, 2025 to the</div>
      <div style="text-align: justify; font-size: 8.5pt;">Product Supplement MLN-ES-ETF-1 dated February 26, 2025 and</div>
      <div style="text-align: justify; font-size: 8.5pt;">Prospectus dated February 26, 2025</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zbb0ddae5f55542f79fa4d9bc38b9a04e" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: top; background-color: rgb(242, 242, 242); border-width: 4px; border-style: solid; border-color: rgb(0, 176, 80);">
              <div style="text-align: center; color: #00B050; font-size: 16pt;">The Toronto-Dominion Bank</div>
              <div style="text-align: center; font-size: 10pt;">$1,400,000</div>
              <div style="text-align: center; font-size: 10pt;">Autocallable Contingent Interest Barrier Notes with Memory Interest Linked to the Least Performing of the shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, the shares of
                the Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and the shares of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust<font style="font-size: 8pt;">&#160;</font>Due December 23, 2027</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; font-size: 7.5pt;">The Toronto-Dominion Bank (&#8220;TD&#8221; or &#8220;we&#8221;) has offered the Autocallable Contingent Interest Barrier Notes with Memory Interest (the &#8220;Notes&#8221;) linked to the least
        performing of the shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, the shares of the Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and the shares of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust<font style="font-size: 8pt;">&#160;</font>(each, a &#8220;Reference Asset&#8221; and together, the &#8220;Reference Assets&#8221;). We also refer to an exchange-traded fund as an &#8220;ETF&#8221;.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-size: 7.5pt;">The Notes will pay a Contingent Interest Payment, plus any previously unpaid Contingent Interest Payment(s) with respect to any previous
        Contingent Interest Observation Date(s) pursuant to the Memory Interest Feature, on a Contingent Interest Payment Date (including the Maturity Date) at a per annum rate of 9.00%<font style="font-size: 8pt;">&#160;</font>(the
        &#8220;Contingent Interest Rate&#8221;<font style="font-size: 8pt;">)</font> only if, on the related Contingent Interest Observation Date, the Closing Value of each Reference Asset is greater than or equal to its Contingent Interest Barrier
        Value, which is equal to 65.00% of its Initial Value. If, however, the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on a Contingent Interest Observation Date, no Contingent Interest Payment will be payable
        on the related Contingent Interest Payment Date. The Notes will be automatically called if, on any Call Observation Date, the Closing Value of each Reference Asset is greater than or equal to its Call Threshold Value, which is equal to 100.00% of
        its Initial Value. If the Notes are automatically called, on the first following Contingent Interest Payment Date (the &#8220;Call Payment Date&#8221;), we will pay a cash payment per Note equal to the Principal Amount, plus any Contingent Interest Payment
        otherwise due and any previously unpaid Contingent Interest Payment(s) with respect to any previous Contingent Interest Observation Date(s) pursuant to the Memory Interest Feature. No further amounts will be owed under the Notes. If the Notes are
        not automatically called, the amount we pay at maturity, in addition to any Contingent Interest Payment(s) otherwise due, if anything, will depend on the Closing Value of each Reference Asset on its Final Valuation Date (each, its &#8220;Final Value&#8221;)
        relative to its Barrier Value, which is equal to 65.00% of its Initial Value, calculated as follows:</div>
      <table cellspacing="0" cellpadding="0" id="z6e81da8e2d1f49188e5cf69b48b12bf9" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 3pt;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 7.5pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 7.5pt;">If the Final Value of each Reference Asset is greater than or equal to its Barrier Value<font style="font-size: 8pt;">:</font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 3pt; font-size: 7.5pt;">the Principal Amount of $1,000</div>
      <table cellspacing="0" cellpadding="0" id="zd795097936134543b64da131125a918a" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 3pt;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 7.5pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 7.5pt;">If the Final Value of any Reference Asset is less than its Barrier Value<font style="font-size: 8pt;">:</font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 3pt; font-size: 7.5pt;">the sum of (1) $1,000 plus (2) the product of (i) $1,000 times (ii) the Least Performing Percentage Change</div>
      <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt;"><font style="font-weight: bold; font-style: italic;">If the Notes are not automatically called and the Final Value of
          any Reference Asset is less than its Barrier Value, investors will suffer a percentage loss on their initial investment that is equal to the percentage decline of the Reference Asset with the lowest Percentage Change from its Initial Value to its
          Final Value (the &#8220;Least Performing Reference Asset&#8221;). Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose
          the entire Principal Amount.</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">Any payments on the Notes are subject to our credit risk.</font></div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="1" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;" id="z48886d14ce26464aac53637f23f73088">

              <tr>
                <td style="width: 1%; border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 98%; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);">
                  <div style="font-size: 8pt; font-weight: bold; text-align: justify;">The Notes do not guarantee the payment of any Contingent Interest Payments or the return of the Principal Amount. Investors are exposed to the market
                    risk of each Reference Asset on each Contingent Interest Observation Date (including the Final Valuation Date) and any decline in the value of one Reference Asset will not be offset or mitigated by a lesser decline or potential increase
                    in the value of any other Reference Asset. If the Final Value of any Reference Asset is less than its Barrier Value, investors may lose up to their entire investment in the Notes. Any payments on the Notes are subject to our credit
                    risk.</div>
                </td>
                <td style="width: 1%; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"><br>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="margin: 3pt 0px 2pt; font-size: 7.5pt; text-align: justify;">The Notes are unsecured and are not savings accounts or insured deposits of a bank. The Notes are not insured or guaranteed by the Canada Deposit Insurance
        Corporation, the U.S. Federal Deposit Insurance Corporation or any other governmental agency or instrumentality of Canada or the United States. The Notes will not be listed or displayed on any securities exchange or electronic communications
        network.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 7.5pt;"><font style="font-weight: bold;">The Notes have complex features and investing in the Notes involves a number of risks.
          See &#8220;Additional Risk Factors&#8221; beginning on page P-7 of this pricing supplement, &#8220;Additional Risk Factors Specific to the Notes&#8221; beginning on page PS-7 of the product supplement MLN-ES-ETF-1 dated February 26, 2025 (the &#8220;product supplement&#8221;)</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold;">and &#8220;Risk Factors&#8221; on page 1 of the prospectus dated February 26, 2025 (the &#8220;prospectus&#8221;).</font></div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 7.5pt; font-weight: bold;">Neither the Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these Notes
        or determined that this pricing supplement, the product supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 7.5pt;">We will deliver the Notes in book-entry only form through the facilities of The Depository Trust Company on the Issue Date against payment in immediately
        available funds.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 7.5pt;">The estimated value of your Notes on the Pricing Date was $983.60 per Note, as discussed further under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated
        Value and Liquidity&#8221; beginning on page P-10 and &#8220;Additional Information Regarding the Estimated Value of the Notes&#8221; on page P-27 of this pricing supplement. The estimated value is less than the public offering price of the Notes.</div>
      <table cellspacing="0" cellpadding="0" id="z849f6391a9844964a7bea5d8b085f1e2" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 17.86%; vertical-align: top; border-bottom: #D9D9D9 1px solid;"><br>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt; font-weight: bold;">Public Offering Price<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt; font-weight: bold;">Underwriting Discount<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1 2</sup></div>
            </td>
            <td style="width: 30.22%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt; font-weight: bold;">Proceeds to TD<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 17.86%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt;">Per Note</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$1,000.00</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$7.00</div>
            </td>
            <td style="width: 30.22%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$993.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 17.86%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt;">Total</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$1,400,000.00</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$9,800.00</div>
            </td>
            <td style="width: 30.22%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$1,390,200.00</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="zdf157620bf8f47888431a1e20e406123" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 5pt;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;">Certain dealers who purchase the Notes for sale to certain fee-based advisory accounts may have agreed to forgo some or all of their selling
                  concessions, fees or commissions. The public offering price for investors purchasing the Notes in these accounts may have been as low as $993.00 (99.30%) per Note.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="ze76fa217f8ad48e98328fcd4a2183c35" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 5pt;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;">TD Securities (USA) LLC (&#8220;TDS&#8221;) will receive a commission of $7.00 (0.70%) per Note and will use all of that commission to allow selling concessions
                  to other dealers in connection with the distribution of the Notes. Such other dealers may resell the Notes to other securities dealers at the Principal Amount less a concession not in excess of $7.00 per Note. TD will reimburse TDS for
                  certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes. See &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221;
                  herein.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 7pt; text-align: justify;">The public offering price, underwriting discount and proceeds to TD listed above relate to the Notes we issue initially. We may decide to sell additional Notes after the date of
        this pricing supplement, at public offering prices and with underwriting discounts and proceeds to TD that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the Notes will depend in part on the
        public offering price you pay for such Notes.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">1</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z3038e26346bd48d091c1a670ac474232" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: middle;"><br>
            </td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: middle;">
              <div style="text-align: right; font-size: 8pt;"><font style="font-weight: bold;">Autocallable Contingent Interest Barrier Notes with Memory Interest Linked to</font></div>
              <div style="text-align: right; font-size: 8pt;"><font style="font-weight: bold;">the Least Performing of the shares of the iShares</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold;"> Russell 2000 ETF, the</font></div>
              <div style="text-align: right; font-size: 8pt;"><font style="font-weight: bold;">shares of the Invesco QQQ Trust</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup><font style="font-weight: bold;">, Series 1 and the shares of the SPDR</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold;"> S&amp;P</font></div>
              <div style="text-align: right; font-size: 8pt;"><font style="font-weight: bold;">500</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold;"> ETF Trust</font></div>
              <div style="margin: 0px 0px 4pt; font-size: 8pt; font-weight: bold; text-align: right;">Due December 23, 2027</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="4" border="0" id="z956295afea504030897fb2a59e77d82c" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: top; background-color: #000000;"><br>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: #00B050; font-size: 16pt;">Summary</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The information in this &#8220;Summary&#8221; section is qualified by the more detailed information set forth in this pricing supplement, the product supplement and the
        prospectus.</div>
      <table cellspacing="0" cellpadding="4" border="0" id="z279fae54560340a8808b27ff3fdae9ae" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 23%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issuer:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Senior Debt Securities, Series H</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Type of Note:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Autocallable Contingent Interest Barrier Notes with Memory Interest</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Term:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Approximately 2 years, subject to an automatic call</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Reference Assets:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">The shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF (Bloomberg ticker: IWM UP, &#8220;IWM&#8221;), the shares of the Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 (Bloomberg ticker: QQQ
                UQ, &#8220;QQQ&#8221;) and the shares of the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust (Bloomberg ticker: SPY UP, &#8220;SPY&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">CUSIP / ISIN:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">89115LCU0 / US89115LCU08</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Agent:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">TDS</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Currency:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">U.S. Dollars</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Minimum Investment:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">$1,000 and minimum denominations of $1,000 in excess thereof</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Principal Amount:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">$1,000 per Note</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Strike Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">December 17, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Pricing Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">December 18, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">December 23, 2025, which is the third DTC settlement day following the Pricing Date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as
                amended (the &#8220;Exchange Act&#8221;), trades in the secondary market generally are required to settle in one DTC settlement day (&#8220;T+1&#8221;), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes in
                the secondary market on any date prior to one DTC settlement day before delivery of the Notes will be required, by virtue of the fact that each Note initially will settle in three DTC settlement days (&#8220;T+3&#8221;), to specify alternative
                settlement arrangements to prevent a failed settlement of the secondary market trade.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Final Valuation Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">The final Contingent Interest Observation Date, as specified below under &#8220;Contingent Interest Observation Dates&#8221;.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold; text-align: justify;">Maturity Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">December 23, 2027, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">2</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" id="zbd323fcd783a4d469ea0b88ff978bacf" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 23%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Call Feature:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">If the Closing Value of each Reference Asset on any Call Observation Date is greater than or equal to its Call Threshold Value, we will automatically
                call the Notes and, on the related Call Payment Date, we will pay you a cash payment per Note equal to the Principal Amount, plus any Contingent Interest Payment(s) otherwise due. No further amounts will be owed to you under the Notes.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Call Threshold Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">With respect to IWM: $247.24<font style="font-size: 8pt;">&#160;</font>(100.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to QQQ: $600.41<font style="font-size: 8pt;">&#160;</font>(100.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to SPY: $671.40<font style="font-size: 8pt;">&#160;</font>(100.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Call Threshold Value for each Reference Asset is determined by the Calculation Agent and is subject to adjustment as described under &#8220;General Terms
                of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Call Observation Dates:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Quarterly, on the 18th calendar day of each March, June, September and December, commencing on March 18, 2026 and ending on September 18, 2027, subject
                to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Call Payment Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">If the Notes are subject to an automatic call, the Call Payment Date will be the Contingent Interest Payment Date immediately following the relevant
                Call Observation Date, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Contingent Interest Payment:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">If the Closing Value of each Reference Asset is greater than or equal to its Contingent Interest Barrier Value on any Contingent Interest Observation
                Date, a Contingent Interest Payment will be paid to you on the corresponding Contingent Interest Payment Date, in an amount equal to:</div>
              <div style="text-align: center; margin-bottom: 6pt;">Principal Amount &#215; Contingent Interest Rate &#215; <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>/<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">4</sub></div>
              <div style="text-align: justify; margin-bottom: 6pt;">If the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on any Contingent Interest Observation Date, no
                Contingent Interest Payment will be paid to you on the corresponding Contingent Interest Payment Date, but may be paid on a future Contingent Interest Payment Date pursuant to the Memory Interest Feature, discussed below.</div>
              <div>All amounts used in or resulting from any calculation relating to a Contingent Interest Payment will</div>
              <div style="text-align: justify; margin-bottom: 6pt;">be rounded upward or downward, as appropriate, to the nearest tenth of a cent.</div>
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Contingent Interest Payments on the Notes are not guaranteed. You will not receive a Contingent Interest Payment on a Contingent
                Interest Payment Date if the Closing Value of any Reference Asset on the related Contingent Interest Observation Date is less than its Contingent Interest Barrier Value.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Memory Interest Feature:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">If a Contingent Interest Payment is not made on a Contingent Interest Payment Date (other than the Maturity Date) because the Closing Value of any
                Reference Asset is less than its Contingent Interest Barrier Value on the related Contingent Interest Observation Date, that Contingent Interest Payment will be made on a later Contingent Interest Payment Date if the Closing Value of each
                Reference Asset is greater than or equal to its Contingent Interest Barrier Value on the related Contingent Interest Observation Date. For the avoidance of doubt, once a previously unpaid Contingent Interest Payment has been made on a later
                Contingent Interest Payment Date, it will not be made again on any subsequent Contingent Interest Payment Date. If the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on each of the Contingent
                Interest Observation Dates, you will not receive any Contingent Interest Payments during the term of, and will not receive a positive return on, the Notes.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Contingent Interest Rate:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">9.00% per annum</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Contingent Interest Barrier</div>
              <div style="font-weight: bold;">Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">With respect to IWM: $160.706<font style="font-size: 8pt;">&#160;</font>(65.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to QQQ: $390.2665<font style="font-size: 8pt;">&#160;</font>(65.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to SPY: $436.41<font style="font-size: 8pt;">&#160;</font>(65.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="text-align: justify;">The Contingent Interest Barrier Value for each Reference Asset is determined by the Calculation Agent and is subject to adjustment as described under &#8220;General Terms of the
                Notes &#8212; Anti-Dilution Adjustments&#8221; in the product supplement.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">3</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" id="zb5a4eae2f0064e30ae8265f111b991e5" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td nowrap="nowrap" style="width: 23%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Contingent Interest</div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Observation Dates:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Quarterly, on the 18th calendar day of each March, June, September and December, commencing on March 18, 2026 and ending on December 20, 2027<font style="font-size: 8pt;">&#160;</font>(the &#8220;Final Valuation Date&#8221;), subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold; text-align: justify;">Contingent Interest Payment</div>
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Dates:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">With respect to each Contingent Interest Observation Date, the third Business Day following the relevant Contingent Interest Observation Date, with the
                exception of the final Contingent Interest Payment Date, which will be the Maturity Date, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Payment at Maturity:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">If the Notes are not automatically called, on the Maturity Date, in addition to any Contingent Interest Payment(s) otherwise due, we will pay a cash
                payment, if anything,<font style="font-size: 8pt;">&#160;</font>per Note equal to:</div>
              <div style="text-align: justify; margin-bottom: 6pt;">If the Final Value of each Reference Asset is greater than or equal to its Barrier Value<font style="font-size: 8pt;">:</font></div>
              <div style="text-align: center; margin-bottom: 6pt;">Principal Amount of $1,000.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">If the Final Value of any Reference Asset is less than its Barrier Value<font style="font-size: 8pt;">:</font></div>
              <div style="text-align: center; margin-bottom: 3pt;">$1,000 + ($1,000 &#215; Least Performing Percentage Change).</div>
              <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-weight: bold; font-style: italic;">If the Notes are not automatically called and the Final Value
                  of any Reference Asset is less than its Barrier Value, investors will suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change. Specifically, investors will lose 1% of the Principal
                  Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">Any payments on the Notes are subject to our credit risk.</font></div>
              <div>All amounts used in or resulting from any calculation relating to the Payment at Maturity will be rounded upward or downward, as appropriate, to the nearest cent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Percentage Change:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">For each Reference Asset, the Percentage Change is the quotient, expressed as a percentage, of the following formula:</div>
              <div style="text-align: center;"><u>Final Value &#8211; Initial Value</u></div>
              <div style="text-align: center; margin-bottom: 6pt;">Initial Value</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Initial Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to IWM: $247.24</div>
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to QQQ: $600.41</div>
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to SPY: $671.40</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Initial Value of each Reference Asset equals its Closing Value on the Strike Date, as determined by the Calculation Agent and subject to adjustment
                as described under &#8220;General Terms of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Closing Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">For each Reference Asset, the Closing Value will be the closing sale price or last reported sale price (or, in the case of Nasdaq, the official closing
                price) for that Reference Asset on a per-share or other unit basis, on any Trading Day for that Reference Asset or, if such Reference Asset is not quoted on any national securities exchange on that day, on any other market system or
                quotation system that is the primary market for the trading of such Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Final Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">For each Reference Asset, the Closing Value of such Reference Asset on its Final Valuation Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Barrier Value:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">With respect to IWM: $160.706<font style="font-size: 8pt;">&#160;</font>(65.00% of its Initial Value).</div>
              <div style="margin-bottom: 6pt;">With respect to QQQ: $390.2665<font style="font-size: 8pt;">&#160;</font>(65.00% of its Initial Value).</div>
              <div style="margin-bottom: 6pt;">With respect to SPY: $436.41<font style="font-size: 8pt;">&#160;</font>(65.00% of its Initial Value).</div>
              <div style="text-align: justify;">The Barrier Value for each Reference Asset is determined by the Calculation Agent and is subject to adjustment as described under &#8220;General Terms of the Notes &#8212;
                Anti-Dilution Adjustments&#8221; in the product supplement.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">4</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" id="z7e212e9fcf764deeae87e10577db98d3" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td nowrap="nowrap" style="width: 23%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Least Performing Reference</div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Asset:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Reference Asset with the lowest Percentage Change as compared to the Percentage Change of any other Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Least Performing Percentage</div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Change:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Percentage Change of the Least Performing Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Monitoring Period:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Final Valuation Date Monitoring</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Trading Day:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">A day on which the principal trading market(s) for each Reference Asset is scheduled to be open for trading, as determined by the Calculation Agent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Business Day:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized
                or required by law to close in New York City.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">U.S. Tax Treatment:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">By purchasing the Notes, you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the
                contrary, to treat the Notes, for U.S. federal income tax purposes, as prepaid derivative contracts with respect to the Reference Assets. Pursuant to this approach, it is likely that any Contingent Interest Payment that you receive should
                be included in ordinary income at the time you receive the payment or when it accrues, depending on your regular method of accounting for U.S. federal income tax purposes. Based on certain factual representations received from us, our
                special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be reasonable to treat the Notes in the manner described above. However, because there is no authority that specifically addresses
                the tax treatment of the Notes, it is possible that your Notes could alternatively be treated for tax purposes as a single contingent payment debt instrument, as a constructive ownership transaction under Section 1260 of the Code (as
                defined herein)<font style="font-size: 8pt;">&#160;</font>or pursuant to some other characterization, such that the timing and character of your income from the Notes could differ materially and adversely from the treatment
                described above, as described further under &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplement. <font style="font-weight: bold;">An investment in the Notes is not
                  appropriate for non-U.S. holders and we will not attempt to ascertain the tax consequences to non-U.S. holders of the purchase, ownership or disposition of the Notes.</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Tax Treatment:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of
                Canadian Tax Consequences&#8221;, which applies to the Notes. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian
                Tax Act (as defined in the prospectus).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Record Date:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Business Day preceding the relevant Contingent Interest Payment Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Calculation Agent:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Listing:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Bail-in:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Notes are not bail-inable debt securities (as defined in the prospectus) under the Canada Deposit Insurance Corporation Act.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold; text-align: justify;">Change in Law Event:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">Not applicable, notwithstanding anything to the contrary in the product supplement.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">5</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: #00B050; font-size: 16pt;">Additional Terms of Your Notes</div>
      <div style="text-align: justify; margin-bottom: 6pt;">You should read this pricing supplement together with the prospectus, as supplemented by the product supplement <font style="font-size: 8.5pt;">MLN-ES-ETF-1 (the &#8220;product supplement&#8221;)</font><font style="font-size: 8pt;">,</font> relating to our Senior Debt Securities, Series H, of which these Notes are a part. Capitalized terms used but not defined in this
        pricing supplement will have the meanings given to them in the product supplement. In the event of any conflict the following hierarchy will govern: first, this pricing supplement; second, the product supplement; and last, the prospectus. <font style="font-weight: bold; font-style: italic;">The Notes vary from the terms described in the product supplement in several important ways. You should read this pricing supplement carefully.</font></div>
      <div style="text-align: justify; margin-bottom: 6pt;">This pricing supplement, together with the documents listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements
        as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully
        consider, among other things, the matters set forth in &#8220;Additional Risk Factors&#8221; herein, &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus, as the Notes involve risks not associated with
        conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes. You may access these documents on the SEC website at www.sec.gov as follows (or if that address
        has changed, by reviewing our filings for the relevant date on the SEC website):</div>
      <table cellspacing="0" cellpadding="0" id="z3b177c87d42c48fbbbf5a48fc2a4d142" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Prospectus dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
      <table cellspacing="0" cellpadding="0" id="z6bb811118eaa4260bba4d09a2f287a33" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Product Supplement MLN-ES-ETF-1 dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006132/ef20044456_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006132/ef20044456_424b3.htm</a></div>
      <div style="text-align: justify; margin-bottom: 6pt;">Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, the &#8220;Bank,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to The
        Toronto-Dominion Bank and its subsidiaries.</div>
      <div style="text-align: justify;">We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will
        notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">6</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: #00B050; font-size: 16pt;">Additional Risk Factors</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Notes involve risks not associated with an investment in conventional debt securities. This section describes the most significant risks relating to the
        terms of the Notes. For additional information as to these and other risks, please see &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Investors should consult their investment, legal, tax, accounting and other advisors as to the risks entailed by an investment in the Notes and the suitability
        of the Notes in light of their particular circumstances.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Return Characteristics</div>
      <div style="margin-bottom: 6pt; font-weight: bold;">Your Investment in the Notes May Result in a Loss.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Notes do not guarantee the return of the Principal Amount and investors may lose up to their entire investment in the Notes. Specifically, if the Notes are
        not automatically called and the Final Value of any Reference Asset is less than its Barrier Value, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than
        its Initial Value, and may lose the entire Principal Amount.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">You Will Not Receive the Contingent Interest Payment With Respect to a Contingent Interest Observation Date on the Corresponding Contingent
        Interest Payment Date if the Closing Value of Any Reference Asset on Such Contingent Interest Observation Date Is Less Than Its Contingent Interest Barrier Value.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">You will not receive a Contingent Interest Payment on a Contingent Interest Payment Date if the Closing Value of any Reference Asset on the related Contingent
        Interest Observation Date is less than its Contingent Interest Barrier Value. However, if a Contingent Interest Payment is not paid on a Contingent Interest Payment Date (other than the Maturity Date) because the Closing Value of any Reference
        Asset is less than its Contingent Interest Barrier Value on the related Contingent Interest Observation Date, pursuant to the Memory Interest Feature such Contingent Interest Payment will be paid on a later Contingent Interest Payment Date if the
        Closing Value of each Reference Asset is greater than or equal to its Contingent Interest Barrier Value on the related Contingent Interest Observation Date. If the Closing Value of any Reference Asset is less than its Contingent Interest Barrier
        Value on each Contingent Interest Observation Date over the term of the Notes, you will not receive any Contingent Interest Payments and, therefore, you will not receive a positive return on your Notes. Generally, this non-payment of any Contingent
        Interest Payment will coincide with a greater risk of principal loss on your Notes at maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Potential Positive Return on the Notes Is Limited to the Contingent Interest Payments Paid on the Notes, if Any, Regardless of Any
        Appreciation of Any Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The potential positive return on the Notes is limited to any Contingent Interest Payments paid, meaning any positive return on the Notes will be composed solely
        of the sum of any Contingent Interest Payments paid over the term of the Notes. Therefore, if the appreciation of any Reference Asset exceeds the sum of any Contingent Interest Payments actually paid on the Notes, the return on the Notes will be
        less than the return on a hypothetical direct investment in such Reference Asset, in a security directly linked to the positive performance of such Reference Asset or a hypothetical investment in the stocks and other assets comprising such
        Reference Asset (its &#8220;Reference Asset Constituents&#8221;).</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Your Return May Be Less Than the Return on a Conventional Debt Security of Comparable Maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The return that you will receive on your Notes, which could be negative, may be less than the return you could earn on other investments. The Notes do not
        provide for fixed interest payments and you may not receive any Contingent Interest Payments over the term of the Notes. Even if you do receive one or more Contingent Interest Payments and your return on the Notes is positive, your return may be
        less than the return you would earn if you bought a conventional, interest-bearing senior debt security of TD of comparable maturity. Your investment may not reflect the full opportunity cost to you when you take into account factors that affect
        the time value of money.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Notes May Be Automatically Called Prior to the Maturity Date and Are Subject to Reinvestment Risk.</div>
      <div style="text-align: justify;">If your Notes are automatically called, no further payments will be owed to you under the Notes after the applicable Call Payment Date. Therefore, because the Notes could be called
        as early as the first potential Call Payment Date, the holding period could be limited. There is no guarantee that you would be able to reinvest the proceeds from an investment in the Notes at a comparable return for a similar level of risk in the
        event the Notes are automatically called prior to the Maturity Date. Furthermore, to the extent you are able to reinvest such proceeds in an investment with a comparable return for a similar level of risk, you may incur transaction costs such as
        dealer discounts and hedging costs built into the price of the new notes.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">7</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Amounts Payable on the Notes Are Not Linked to the Value of the Least Performing Reference Asset at Any Time Other Than on the Contingent
        Interest Observation Dates (Including the Final Valuation Date) And Call Observation Dates.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Any payments on the Notes will be based on the Closing Value of the Least Performing Reference Asset only on the Contingent Interest Observation Dates
        (including the Final Valuation Date) and Call Observation Dates. Even if the value of the Least Performing Reference Asset appreciates prior to a Contingent Interest Observation Date but then drops on that day to a Closing Value that is less than
        its Contingent Interest Barrier Value, you will not receive any Contingent Interest Payment with respect to such Contingent Interest Observation Date on the corresponding Contingent Interest Payment Date. Similarly, the Payment at Maturity may be
        significantly less than it would have been had the Notes been linked to the Closing Value of the Least Performing Reference Asset on a date other than the Final Valuation Date, and may be zero. Although the actual values of the Reference Assets at
        other times during the term of the Notes may be higher than the values on one or more Contingent Interest Observation Dates (including the Final Valuation Date) or Call Observation Dates, any Contingent Interest Payments on the Notes and the
        Payment at Maturity will be based solely on the Closing Value of the Least Performing Reference Asset on the applicable Contingent Interest Observation Date (including the Final Valuation Date) and Call Observation Dates.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Contingent Interest Rate Will Reflect, in Part, the Volatility of Each Reference Asset and May Not Be Sufficient to Compensate You for
        the Risk of Loss at Maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Generally, the higher a Reference Asset&#8217;s volatility, the more likely it is that the Closing Value of that Reference Asset could be less than its Call Threshold
        Value or its Contingent Interest Barrier Value on a Call Observation Date or Contingent Interest Observation Date or its Barrier Value on its Final Valuation Date. Volatility means the magnitude and frequency of changes in the value of a Reference
        Asset. This greater risk will generally be reflected in a higher Contingent Interest Rate for the Notes than the interest rate payable on our conventional debt securities with a comparable term. However, while the Contingent Interest Rate is set on
        the Strike Date, a Reference Asset&#8217;s volatility can change significantly over the term of the Notes, and may increase. The value of any Reference Asset could fall sharply on the Contingent Interest Observation Dates, resulting in few or no
        Contingent Interest Payments or on the Final Valuation Date, resulting in a loss of a significant portion or all of the Principal Amount.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">You Will Have No Rights to Receive Any Shares of Any Reference Asset and You Will Not Be Entitled to Any Dividends or Other Distributions on
        Any Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Notes are our debt securities. They are not equity instruments, shares of stock, or securities of any other issuer. Investing in the Notes will not make you
        a holder of shares of any Reference Asset. You will not have any voting rights, any rights to receive dividends or other distributions, or any rights against the issuer of any Reference Asset. As a result, the return on your Notes may not reflect
        the return you would realize if you actually owned shares of any Reference Asset and received any dividends paid or other distributions made in connection with them. Your Notes will be paid in cash and you have no right to receive delivery of
        shares of any Reference Asset.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Characteristics of the Reference Assets</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There Are Market Risks Associated With Each Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The value of each Reference Asset can rise or fall sharply due to factors specific to such Reference Asset, its investment adviser (its &#8220;Investment Adviser&#8221;)
        and its Reference Asset Constituents and their issuers (the &#8220;Reference Asset Constituent Issuers&#8221;), such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions
        and other events, as well as general market factors, such as general stock market volatility and levels, interest rates and economic and political conditions. You, as an investor in the Notes, should make your own investigation into the Investment
        Advisers and the Reference Assets for your Notes. For additional information, see &#8220;Information Regarding the Reference Assets&#8221; in this pricing supplement and each Investment Adviser's SEC filings. <font style="font-weight: bold;">We urge you to review financial and other information filed periodically by the Investment Advisers with the SEC.</font></div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Investors Are Exposed to the Market Risk of Each Reference Asset on Each Contingent Interest Observation Date (Including the Final Valuation
        Date).</div>
      <div style="text-align: justify;">Your return on the Notes is not linked to a basket consisting of the Reference Assets. Rather, it will be contingent upon the performance of each Reference Asset. Unlike an
        instrument with a return linked to a basket of indices, common stocks or other underlying securities, in which risk is mitigated and diversified among all of the components of the basket, you will be exposed equally to the risks related to each
        Reference Asset on each Contingent Interest Observation Date (including the Final Valuation Date). Poor performance by any Reference Asset over the term of the Notes will negatively affect your return and will not be offset or mitigated by a
        positive performance by any other Reference Asset. For instance, if the Final Value of any Reference Asset is less than its Barrier Value on its Final Valuation Date, you will receive a negative return equal to the Least Performing Percentage
        Change,<font style="font-size: 8pt;">&#160;</font>even if the Percentage Change of another Reference Asset is positive or has not declined as much. Accordingly, your investment is subject to the market risk of each Reference Asset.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">8</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Because the Notes Are Linked to the Least Performing Reference Asset, You Are Exposed to a Greater Risk of No Contingent Interest Payments
        and Losing a Significant Portion or All of Your Initial Investment at Maturity Than if the Notes Were Linked to a Single Reference Asset or Fewer Reference Assets.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The risk that you will not receive any Contingent Interest Payments and lose a significant portion or all of your initial investment in the Notes is greater if
        you invest in the Notes than the risk of investing in substantially similar securities that are linked to the performance of only one Reference Asset or fewer Reference Assets. With more Reference Assets, it is more likely that the Closing Value of
        any Reference Asset will be less than its Contingent Interest Barrier Value on any Contingent Interest Observation Date (including the Final Valuation Date) and that the Final Value of any Reference Asset will be less than its Barrier Value on the
        Final Valuation Date than if the Notes were linked to a single Reference Asset or fewer Reference Assets.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">In addition, the lower the correlation is between the performance of a pair of Reference Assets, the more likely it is that one of the Reference Assets will
        decline in value to a Closing Value or Final Value, as applicable, that is less than its Contingent Interest Barrier Value or Barrier Value on any Call Observation Date or Contingent Interest Observation Date (including the Final Valuation Date).
        Although the correlation of the Reference Assets&#8217; performance may change over the term of the Notes, the economic terms of the Notes, including the Contingent Interest Rate, Contingent Interest Barrier Value and Barrier Value are determined, in
        part, based on the correlation of the Reference Assets&#8217; performance calculated using our internal models at the time when the terms of the Notes are finalized. All things being equal, a higher Contingent Interest Rate and lower Contingent Interest
        Barrier Values and Barrier Values are generally associated with lower correlation of the Reference Assets. Therefore, if the performance of a pair of Reference Assets is not correlated to each other or is negatively correlated, the risk that you
        will not receive any Contingent Interest Payments or that the Final Value of any Reference Asset is less than its Barrier Value will occur is even greater despite a lower Contingent Interest Barrier Value and Barrier Value, respectively. Therefore,
        it is more likely that you will not receive any Contingent Interest Payments and that you will lose a significant portion or all of your initial investment at maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Value of a Reference Asset May Not Completely Track Its NAV.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The net asset value (&#8220;NAV&#8221;) of an ETF, including the Reference Assets, may fluctuate with changes in the market value of its Reference Asset Constituents. The
        market values of an ETF may fluctuate in accordance with changes in NAV and supply and demand on the applicable stock exchange(s). Furthermore, the Reference Asset Constituents may be unavailable in the secondary market during periods of market
        volatility, which may make it difficult for market participants to accurately calculate the intraday NAV per share of the applicable Reference Asset and may adversely affect the liquidity and prices of such Reference Asset, perhaps significantly.
        For any of these reasons, the market value of a Reference Asset may differ from its NAV per share and may trade at, above or below its NAV per share.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">We Have No Affiliation With Any Index Sponsor or Investment Adviser and Will Not Be Responsible for Any Actions Taken by Any Such Entity.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">No Index Sponsor or Investment Adviser is an affiliate of ours and no such entity will be involved in the offering of the Notes in any way. Consequently, we
        have no control over the actions of any Index Sponsor or Investment Adviser, including any actions of the type that would require the Calculation Agent to adjust any amount payable on the Notes. No Index Sponsor or Investment Adviser has any
        obligation of any sort with respect to the Notes. Thus, no Index Sponsor or Investment Adviser has any obligation to take your interests into consideration for any reason, including in taking any actions that might affect the value of the
        applicable Reference Asset or the Notes. None of our proceeds from the issuance of the Notes will be delivered to any Index Sponsor or Investment Adviser.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Adjustments to a Reference Asset Could Adversely Affect the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Investment Advisers (as specified under &#8220;Information Regarding the Reference Assets&#8221;) are responsible for calculating and maintaining their applicable
        Reference Asset. An Investment Adviser can add, delete or substitute the Reference Asset Constituents for its Reference Asset. An Investment Adviser may make other methodological changes to its Reference Asset that could change the value of such
        Reference Asset at any time. If one or more of these events occurs, the Closing Value of such Reference Asset may be adjusted to reflect such event or events, which could adversely affect whether and the extent to which any amounts may be payable
        on the Notes and/or the market value of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Changes that Affect the Target Index of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust Will Affect the Market Value of, and Return on, the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust is an ETF that seeks
        to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of its Target Index (as specified herein). The policies of the sponsor of its Target Index (an &#8220;Index Sponsor&#8221;) concerning the
        calculation of its Target Index, additions, deletions or substitutions of the components of its Target Index and the manner in which changes affecting those components, such as stock dividends, reorganizations or mergers, may be reflected in its
        Target Index and, therefore, could adversely affect the return on the Notes and the market value of the Notes prior to maturity. The market value of, and return on, the Notes could also be affected if the sponsor of its Target Index changes these
        policies, for example, by changing the manner in which it calculates its Target Index. Some of the risks that relate to a target index of an ETF include those discussed in the product supplement, which you should review.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Performance of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        ETF Trust May Not Correlate With That of Its Target Index.</div>
      <div style="text-align: justify;">The performance of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust may not exactly
        replicate the performance of its Target Index because the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust will reflect transaction costs and fees that are not
        included in the calculation of its Target Index. It is also possible that the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust may not fully replicate or may in
        certain</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">9</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt;">circumstances diverge significantly from the performance of its Target Index due to the temporary unavailability of certain securities in the secondary market,
        the performance of any derivative instruments contained in the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust, differences in trading hours between the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust and its Target Index or due to other circumstances.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There Are Liquidity and Management Risks Associated with an ETF and the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>,
        Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust Utilizes a Passive Indexing Investment Approach.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">&#160;Although shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust
        are listed for trading on a securities exchange and a number of similar products have been traded on various exchanges for varying periods of time, there is no assurance that an active trading market will continue for such shares or that there will
        be liquidity in that trading market. The iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust is subject to management risk, which is the risk that its Investment
        Adviser&#8217;s investment strategy, the implementation of which is subject to a number of constraints, may not produce the intended results. Additionally, the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust is not managed according to traditional methods of &#8220;active&#8221; investment management, which involves the buying and selling of securities based on economic, financial and market analysis and investment judgment.
        Instead, utilizing a &#8220;passive&#8221; or indexing investment approach, it attempts to approximate the investment performance of its Target Index by investing in Reference Asset Constituents that generally replicate its Target Index. Therefore, unless a
        specific stock is removed from its Target Index, the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF, Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 and SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust generally would not sell a stock because that stock&#8217;s issuer
        was in financial trouble.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Notes are Subject to Risks Associated with Small-Capitalization Companies.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Notes are subject to risks associated with small-capitalization companies because the Reference Asset Constituents of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000
        ETF are considered small-capitalization companies. These companies often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization companies and therefore such index may be more volatile than an index in
        which a greater percentage of its constituents are issued by large-capitalization companies. Stock prices of small-capitalization companies are also more vulnerable than those of large-capitalization companies to adverse business and economic
        developments, and the stocks of small-capitalization companies may be thinly traded. In addition, small-capitalization companies are typically less stable financially than large-capitalization companies and may depend on a small number of key
        personnel, making them more vulnerable to loss of personnel. Small-capitalization companies are often given less analyst coverage and may be in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller
        revenues, less diverse product lines, smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization companies and are more susceptible to adverse developments related to their
        products.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Estimated Value and Liquidity</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Less Than the Public Offering Price of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of your Notes is less than the public offering price of your Notes. The difference between the public offering price of your Notes and the
        estimated value of the Notes reflects costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes. Because hedging our obligations entails risks and may be influenced by market
        forces beyond our control, this hedging may result in a profit that is more or less than expected, or a loss.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of your Notes is determined by reference to our internal funding rate. The internal funding rate used in the determination of the estimated
        value of the Notes generally represents a discount from the credit spreads for our conventional, fixed-rate debt securities and the borrowing rate we would pay for our conventional, fixed-rate debt securities. This discount is based on, among other
        things, our view of the funding value of the Notes as well as the higher issuance, operational and ongoing liability management costs of the Notes in comparison to those costs for our conventional, fixed-rate debt, as well as estimated financing
        costs of any hedge positions, taking into account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional, fixed-rate debt securities, or the borrowing rate we would pay for our conventional,
        fixed-rate debt securities were to be used, we would expect the economic terms of the Notes to be more favorable to you. Additionally, assuming all other economic terms are held constant, the use of an internal funding rate for the Notes is
        expected to increase the estimated value of the Notes at any time.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of the Notes Is Based on Our Internal Pricing Models, Which May Prove to Be Inaccurate and May Be Different From the
        Pricing Models of Other Financial Institutions.</div>
      <div style="text-align: justify;">The estimated value of your Notes is based on our internal pricing models, which take into account a number of variables, such as our internal funding rate on the Pricing Date, and
        are based on a number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different from other financial institutions&#8217; pricing models and the
        methodologies used by us to estimate the value of the Notes may not be consistent with those of other financial institutions that may be purchasers or sellers of Notes in the secondary market. As a result, the secondary market price of your Notes
        may be materially less than the estimated value of the Notes determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the future may change, and any assumptions may prove to be incorrect.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">10</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, if Any, and
        Such Secondary Market Prices, if Any, Will Likely Be Less Than the Public Offering Price of Your Notes and May Be Less Than the Estimated Value of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of the Notes is not a prediction of the prices at which the Agent, other affiliates of ours or third parties may be willing to purchase the
        Notes from you in secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market at any time, if any, will be influenced by many
        factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the estimated value of the Notes. Further, as secondary market prices of your Notes take into
        account the levels at which our debt securities trade in the secondary market, and do not take into account our various costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the
        Notes, secondary market prices of your Notes will likely be less than the public offering price of your Notes. As a result, the price at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in
        secondary market transactions, if any, will likely be less than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Temporary Price at Which the Agent May Initially Buy the Notes in the Secondary Market May Not Be Indicative of Future Prices of Your
        Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary
        market (if the Agent makes a market in the Notes, which it is not obligated to do) may exceed the estimated value of the Notes on the Pricing Date, as well as the secondary market value of the Notes, for a temporary period after the Issue Date of
        the Notes, as discussed further under &#8220;Additional Information Regarding the Estimated Value of the Notes.&#8221; The price at which the Agent may initially buy or sell the Notes in the secondary market may not be indicative of future prices of your
        Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Underwriting Discount, Offering Expenses and Certain Hedging Costs Are Likely to Adversely Affect Secondary Market Prices.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Assuming no changes in market conditions or any other relevant factors, the price, if any, at which you may be able to sell the Notes will likely be less than
        the public offering price. The public offering price includes, and any price quoted to you is likely to exclude, any underwriting discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our
        obligations under the Notes. In addition, any such price is also likely to reflect dealer discounts, mark-ups and other transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge
        transaction.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There May Not Be an Active Trading Market for the Notes &#8212; Sales in the Secondary Market May Result in Significant Losses.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">There may be little or no secondary market for the Notes. The Notes will not be listed or displayed on any securities exchange or electronic communications
        network. The Agent or another one of our affiliates may make a market for the Notes; however, it is not required to do so and may stop any market-making activities at any time. Even if a secondary market for the Notes develops, it may not provide
        significant liquidity or trade at prices advantageous to you. We expect that transaction costs in any secondary market would be high. As a result, the difference between bid and ask prices for your Notes in any secondary market could be
        substantial.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">If you sell your Notes before the Maturity Date, you may have to do so at a substantial discount from the public offering price irrespective of the value of the
        then-current least performing Reference Asset, and as a result, you may suffer substantial losses.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">If the Value of Any Reference Asset Changes, the Market Value of Your Notes May Not Change in the Same Manner.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Your Notes may trade quite differently from the performance of any of the Reference Assets. Changes in the value of any Reference Asset may not result in a
        comparable change in the market value of your Notes. Even if the Closing Value of each Reference Asset remains greater than or equal to its Barrier Value and Contingent Interest Barrier Value or increases to greater than its Call Threshold Value
        during the term of the Notes, the market value of your Notes may not increase by the same amount and could decline.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Hedging Activities and Conflicts of Interest</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There Are Potential Conflicts of Interest Between You and the Calculation Agent.</div>
      <div style="text-align: justify;">The Calculation Agent will, among other things, determine the amounts payable on the Notes. We will serve as the Calculation Agent and may appoint a different Calculation Agent
        after the Issue Date without notice to you. The Calculation Agent will exercise its judgment when performing its functions and may have a conflict of interest if it needs to make certain decisions. For example, the Calculation Agent may have to
        determine whether a market disruption event affecting a Reference Asset has occurred, and make certain adjustments if certain events occur, which may, in turn, depend on the Calculation Agent&#8217;s judgment as to whether the event has materially
        interfered with our ability or the ability of one of our affiliates to unwind our hedge positions. Because this determination by the Calculation Agent may affect the amounts payable on the Notes, the Calculation Agent may have a conflict of
        interest if it needs to make a determination of this kind. For additional information on the Calculation Agent&#8217;s role, see &#8220;General Terms of the Notes &#8212; Role of Calculation Agent&#8221; in the product supplement.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">11</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">You Will Have Limited Anti-Dilution Protection and, in Certain Situations, Your Return on the Notes May be Based on a Substitute Reference
        Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Calculation Agent may adjust the Initial Value, and therefore the Call Threshold Value, Contingent Interest Barrier Value and Barrier Value of a Reference
        Asset for stock splits, reverse stock splits, stock dividends, extraordinary dividends and other events that affect such Reference Asset, but only in the situations we describe in &#8220;General Terms of the Notes &#8212; Anti-Dilution Adjustments&#8221; in the
        product supplement. The Calculation Agent will not be required to make an adjustment for every event that may affect a Reference Asset. Furthermore, in certain situations, such as when a Reference Asset undergoes a Reorganization Event or a
        Reference Asset is delisted, such Reference Asset may be replaced by distribution property or a substitute equity security, as discussed more fully in the product supplement under &#8220;General Terms of the Notes&#8221;. Notwithstanding the Calculation
        Agent&#8217;s ability to make adjustments to the terms of the Notes and the Reference Assets, those events or other actions affecting a Reference Asset, Reference Asset Constituent Issuer, Investment Adviser or a third party may nevertheless adversely
        affect the price of the applicable Reference Asset and, therefore, adversely affect the market value of, and return on, your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Contingent Interest Observation Dates (Including the Final Valuation Date), Call Observation Dates and the Related Payment Dates Are
        Subject to Market Disruption Events and Postponements.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Each Contingent Interest Observation Date (including the Final Valuation Date), Call Observation Date and related payment date (including the Maturity Date) is
        subject to postponement due to the occurrence of one or more market disruption events. For a description of what constitutes a market disruption event as well as the consequences of that market disruption event, see &#8220;General Terms of the Notes &#8212;
        Market Disruption Events&#8221; in the product supplement. A market disruption event for a particular Reference Asset will not constitute a market disruption event for any other Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Trading and Business Activities by TD or Its Affiliates May Adversely Affect the Market Value Of, and Any Amounts Payable On, the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">We, the Agent and/or our other affiliates may hedge our obligations under the Notes by purchasing securities, futures, options or other derivative instruments
        with returns linked or related to changes in the value of a Reference Asset or one or more Reference Asset Constituents, and we may adjust these hedges by, among other things, purchasing or selling at any time any of the foregoing assets. It is
        possible that we or one or more of our affiliates could receive substantial returns from these hedging activities while the market value of the Notes declines. We or one or more of our affiliates may also issue or underwrite other securities or
        financial or derivative instruments with returns linked or related to changes in a Reference Asset or one or more Reference Asset Constituents.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">These trading activities may present a conflict between the holders&#8217; interest in the Notes and the interests we and our affiliates will have in our or their
        proprietary accounts, in facilitating transactions, including options and other derivatives transactions, for our or their customers&#8217; accounts and in accounts under our or their management. These trading activities could be adverse to the interests
        of the holders of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="color: #000000;">We, the Agent and/or our other affiliates may, </font>at present or in the future, engage in
        business with one or more Reference Asset Constituent Issuers, including making loans to or providing advisory services to those companies. These services could include investment banking and merger and acquisition advisory services. These business
        activities may present a conflict between <font style="color: #000000;">our, the Agent&#8217;s and/or our other affiliates&#8217; obligations</font>, and your interests as a holder of the Notes. Moreover, we, the Agent
        and/or our <font style="color: #000000;">other </font>affiliates may have published, and in the future expect to publish, research reports with respect to a Reference Asset or one or more Reference Asset
        Constituents. This research is modified from time to time without notice and may express opinions or provide recommendations that are inconsistent with purchasing or holding the Notes. Any of these activities by us and/or our <font style="color: #000000;">other </font>affiliates may affect the value of a Reference Asset and, therefore, the market value of, and any amounts payable on, the Notes.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to General Credit Characteristics</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Investors Are Subject to TD&#8217;s Credit Risk, and TD&#8217;s Credit Ratings and Credit Spreads May Adversely Affect the Market Value of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Although the return on the Notes will be based on the performance of the Least Performing Reference Asset, the payment of any amount due on the Notes is subject
        to TD&#8217;s credit risk. The Notes are TD&#8217;s senior unsecured debt obligations. Investors are dependent on TD&#8217;s ability to pay all amounts due on the Notes and, therefore, investors are subject to the credit risk of TD and to changes in the market&#8217;s
        view of TD&#8217;s creditworthiness. Any decrease in TD&#8217;s credit ratings or increase in the credit spreads charged by the market for taking TD&#8217;s credit risk is likely to adversely affect the market value of the Notes. If TD becomes unable to meet its
        financial obligations as they become due, investors may not receive any amounts due under the terms of the Notes.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Canadian and U.S. Federal Income Taxation</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Significant Aspects of the Tax Treatment of the Notes Are Uncertain.</div>
      <div style="text-align: justify;">The U.S. tax treatment of the Notes is uncertain. Please read carefully the section entitled &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplement.
        You should consult your tax advisor as to the tax consequences of your investment in the Notes.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">12</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">For a discussion of the Canadian federal income tax consequences of investing in the Notes, please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221;
        and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the further discussion herein under &#8220;Summary&#8221;. If you are not a Non-resident Holder (as that term is defined in the prospectus) for Canadian federal
        income tax purposes or if you acquire the Notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Notes and receiving the payments that might be due under the Notes.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">13</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; color: #00B050; font-size: 16pt;">Hypothetical Returns</div>
      <div style="text-align: justify; margin-top: 6pt;">The examples set out below are included for illustration purposes only and are hypothetical examples only; amounts below may have been rounded for ease of
        analysis. The hypothetical Initial Values, Closing Values, Final Values and<font style="font-weight: bold;">&#160;</font>Percentage Changes of the Reference Assets used to illustrate the calculation of whether a
        Contingent Interest Payment is payable on a Contingent Interest Payment Date and the Payment at Maturity are not estimates or forecasts of the actual Initial Value, Closing Value or Final Value of any Reference Asset, or the value of any Reference
        Asset on any Trading Day prior to the Maturity Date. All examples assume, for Reference Asset A, Reference Asset B and Reference Asset C, respectively, Initial Values of $200.00, $600.00 and $700.00, Call Threshold Values of $200.00, $600.00 and
        $700.00 (each 100.00% of its Initial Value), Contingent Interest Barrier Values of $130.00, $390.00 and $455.00 (each 65.00% of its Initial Value), Barrier Values of $130.00, $390.00 and $455.00 (each 65.00% of its Initial Value), a Contingent
        Interest Payment of $22.50 per Note (reflecting the Contingent Interest Rate of 9.00% per annum), that a holder purchased Notes with a Principal Amount of $1,000 and that no market disruption event occurs on any Call Observation Date or Contingent
        Interest Observation Date (including the Final Valuation Date). The actual terms of the Notes are set forth elsewhere in this pricing supplement.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Example 1 &#8212; The Closing Value of Each Reference Asset is Greater Than or Equal to its Call Threshold Value on the First Call Observation Date
        and the Notes are Automatically Called.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="za342b4cedfb7475b890bde88c884b18d" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 48%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">First Contingent Interest Observation Date and First Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 48%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: $220.00 (<font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and
                Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: $720.00 (<font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and
                Contingent Interest Barrier Value)</div>
              <div style="margin: 3pt 0px 12pt;">Reference Asset C: $805.00 (<font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value
                and Contingent Interest Barrier Value)&#160;</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 6pt;">$1,000.00 (Principal Amount)</div>
              <div><u>+ $22.50</u> (Contingent Interest Payment)</div>
              <div>$1,022.50 (Total Payment upon Automatic Call)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 48%; vertical-align: top;">
              <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,022.50 (2.25% total return)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">Because the Closing Value of each Reference Asset is greater than or equal to its Call Threshold Value (and therefore also greater than its Contingent Interest
        Barrier Value) on the first Call Observation Date (which is approximately 3 months after the Pricing Date), the Notes will be automatically called and, on the corresponding Call Payment Date, we will pay you a cash payment equal to $1,022.50 per
        Note, reflecting the Principal Amount plus the applicable Contingent Interest Payment, for a total return of 2.25% on the Notes. No further amounts will be owed under the Notes.&#160;</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">14</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-weight: bold; text-align: justify;">Example 2 &#8212; The Closing Value of at Least One Reference Asset is Less Than its Contingent Interest Barrier Value on Each Contingent Interest Observation Date
        Prior to the Final Valuation Date, the Notes are NOT Automatically Called on Any Call Observation Date and the Final Value of Each Reference Asset is Greater Than or Equal to its Barrier Value and Contingent Interest Barrier Value.</div>
      <table cellspacing="0" cellpadding="0" id="z70e10c2e042f4006bc9d97ef8307c8bd" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 48%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">First Contingent Interest Observation Date and First Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 48%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: $97.50 (<font style="font-weight: bold;">less than</font> its Call Threshold Value and Contingent
                Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: $558.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: $553.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">Second through Seventh Contingent Interest Observation Date and Second through Seventh Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 48%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value
                and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">less than</font> its Call Threshold Value and Contingent
                Interest Barrier Value)</div>
              <div style="margin: 3pt 0px 15pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold
                Value and Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">Final Valuation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 48%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: $240.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: $630.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: $805.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value and Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 6pt;">$1,000.00 (Principal Amount)</div>
              <div><u>+ $180.00</u> (Contingent Interest Payment and previously unpaid Contingent Interest Payments in respect of the
                First through Seventh Contingent Interest Observation Dates)</div>
              <div>$1,180.00 (Total Payment on Maturity Date)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 48%; vertical-align: top;">
              <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,180.00 (18.00% total return)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">Because the Closing Value of at least one Reference Asset is less than its Contingent Interest Barrier Value on each Contingent Interest Observation Date prior to
        the Final Valuation Date (and therefore also less than its Call Threshold Value on each Call Observation Date), we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be
        automatically called. Because the Final Value of each Reference Asset is greater than or equal to its Barrier Value and Contingent Interest Barrier Value, on the Maturity Date we will pay you a cash payment equal to $1,180.00 per Note, reflecting
        your Principal Amount plus the Contingent Interest Payment applicable to the Final Valuation Date and the previously unpaid Contingent Interest Payment(s) in respect of the prior Contingent Interest Observation Date(s), for a total return of 18.00%
        on the Notes.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">15</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin: 0px 0px 10pt; font-weight: bold; text-align: justify;">Example 3 &#8212; The Closing Value of at Least One Reference Asset is Less Than its Contingent Interest Barrier Value on Each Contingent
        Interest Observation Date Prior to the Final Valuation Date, the Notes are NOT Automatically Called on Any Call Observation Date and the Final Value of At Least One Reference Asset is Less Than its Contingent Interest Barrier Value and Barrier
        Value.</div>
      <table cellspacing="0" cellpadding="0" id="zd60bb5cb073943eb82232f209103b4a9" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 48%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; padding-bottom: 1px;"><br>
            </td>
            <td style="width: 25%; vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">First Contingent Interest Observation Date and First Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 48%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: $123.50 (<font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value and
                Call Threshold Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: $432.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: $553.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">Second through Seventh Contingent Interest Observation Date and Second through Seventh Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 48%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value
                and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all<font style="font-weight: bold;"> less than</font> its Call Threshold Value and Contingent
                Interest Barrier Value)</div>
              <div style="margin: 3pt 0px 15pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold
                Value and Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">Final Valuation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 48%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: $80.00 (<font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value and
                Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: $750.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: $770.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value and Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,000 + ($1,000 &#215; Least Performing Percentage Change) =</div>
              <div style="margin-top: 3pt;">$1,000 + ($1,000 &#215; -60.00%) =</div>
              <div style="margin-top: 3pt;">$400.00</div>
              <div style="margin-top: 3pt;">(Payment at Maturity)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 48%; vertical-align: top;">
              <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
            </td>
            <td style="width: 1%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;">
              <div style="margin-top: 3pt;">$400.00 (60.00% loss)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">Because the Closing Value of at least one Reference Asset is less than its Contingent Interest Barrier Value on each Contingent Interest Observation Date prior to
        the Final Valuation Date (and therefore also less than its Call Threshold Value on each Call Observation Date), we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be
        automatically called. Because the Final Value of at least one Reference Asset is less than its Contingent Interest Barrier Value and Barrier Value, on the Maturity Date we will pay you a cash payment that is less than the Principal Amount, if
        anything, equal to the Principal Amount plus the product of the Principal Amount and the Least Performing Percentage Change,<font style="font-size: 8pt;">&#160;</font>for a total of $400.00 per Note, a loss of 60.00% per Note.&#160;</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">In this scenario, investors will suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change.
        Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</div>
      <div style="margin: 6pt 0px 0px; font-weight: bold; text-align: justify;">Any payments on the Notes are subject to our credit risk.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">16</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin: 0px 0px 6pt; color: #00B050; font-size: 16pt; text-align: justify;">Information Regarding the Reference Assets</div>
      <div style="text-align: justify; margin-bottom: 6pt;">All disclosures contained in this document regarding the Reference Assets, including, without limitation, their make-up, method of calculation, and changes in
        any Reference Asset Constituents, have been derived from publicly available sources. We have not undertaken an independent review or due diligence of any publicly available information with respect to any Reference Asset. The information reflects
        the policies of, and is subject to change by, the Investment Advisers. The Investment Advisers, which own the copyright and all other rights to the Reference Assets, have no obligation to continue to publish, and may discontinue publication of, the
        applicable Reference Asset. None of the websites referenced in the Reference Asset descriptions below, or any materials included in those websites, are incorporated by reference into this document or any document incorporated herein by reference.
        We have not independently verified the accuracy or completeness of reports filed by an Investment Adviser with the SEC, information published by it on its website or in any other format, information about it obtained from any other source or the
        information provided below.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Each Reference Asset is registered under the Securities Act of 1933, the Investment Company Act of 1940, each as amended, and/or the Exchange Act. Companies
        with securities registered with the SEC are required to file financial and other information specified by the SEC periodically. Information filed by each Investment Adviser with the SEC can be reviewed electronically through a website maintained by
        the SEC. The address of the SEC&#8217;s website is http://www.sec.gov. Information filed with the SEC by each Reference Asset can be located by reference to its SEC file number provided below.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The graphs below set forth the information relating to the historical performance of each Reference Asset. The graphs below show the daily historical Closing
        Values of each Reference Asset for the periods specified. We obtained the information regarding the historical performance of each Reference Asset in the graphs below from Bloomberg Professional<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> service (&#8220;Bloomberg&#8221;). The Closing Values
        may be adjusted by Bloomberg for corporate actions such as stock splits, public offerings, mergers and acquisitions, spin-offs, delistings and bankruptcy.</div>
      <div style="text-align: justify;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of each Reference Asset should not be taken
        as an indication of its future performance, and no assurance can be given as to the Final Value of any Reference Asset. We cannot give you any assurance that the performance of the Reference Assets will result in a positive return on your initial
        investment.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">17</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z503f2627378d427c8b51619766470dfb" style="border-collapse: collapse; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

          <tr>
            <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="font-weight: bold;">iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">We have derived all information contained herein regarding the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF (the &#8220;IWM Fund&#8221;) and the target index, as defined below, from
        publicly available information. Such information reflects the policies of, and is subject to changes by, the IWM Fund&#8217;s investment adviser, BlackRock Fund Advisors (&#8220;BFA&#8221; or the &#8220;investment adviser&#8221;) and the index sponsor of the target index, as
        defined below.</div>
      <div style="text-align: justify; margin-top: 6pt;">The IWM Fund is one of the separate investment portfolios that constitute the iShares Trust (&#8220;iShares&#8221;). The IWM Fund seeks to provide investment results that
        correspond generally to the price and yield performance, before fees and expenses, of the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (the &#8220;target index&#8221;). The target index seeks to measure the performance of the small-capitalization segment of the U.S. equity
        market. The target index is a subset of the Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index, which measures the performance of the largest 3,000 U.S. companies, and the target index is composed of the smallest 2,000 companies included in the Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>
        Index. The target index is calculated, maintained and published by, FTSE Russell (the &#8220;index sponsor&#8221;). The index sponsor is under no obligation to continue to publish, and may discontinue or suspend the publication of, the target index at any
        time.</div>
      <div style="text-align: justify; margin-top: 6pt;">BFA uses a representative sampling strategy to manage the IWM Fund. &#8220;Representative sampling&#8221; is an indexing strategy that involves investing in a representative
        sample of the securities included in the target index that the investment adviser determines to collectively have an investment profile similar to that of the target index. The securities selected are intended to have, in the aggregate, investment
        characteristics (based on market capitalization and industry weightings), fundamental characteristics (such as return variability and yield) and liquidity measures similar to those of the target index. The IWM Fund may or may not hold all of the
        securities that are included in the target index.</div>
      <div style="text-align: justify; margin-top: 6pt;">The IWM Fund generally invests at least 80% of its assets in securities of the target index and in depositary receipts representing securities of the target index.
        The IWM Fund may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, including shares of money market funds advised by BFA or its affiliates, as well as in securities not included in the
        target index, but which BFA believes will help track the target index. The IWM Fund will concentrate its investments (i.e., hold 25% or more of its total assets) in the stocks of a particular industry or group of industries to approximately the
        same extent that the target index is concentrated.</div>
      <div style="text-align: justify; margin-top: 6pt;">Select information regarding the IWM Fund&#8217;s expense ratio and its top constituents, country, industry and/or sector weightings may be made available on the IWM
        Fund&#8217;s website. Expenses of the IWM Fund reduce the net asset value of the assets held by the IWM Fund and, therefore, reduce the value of the shares of the IWM Fund.</div>
      <div style="text-align: justify; margin-top: 6pt;">Shares of the IWM Fund are listed on the NYSE Arca under the ticker symbol &#8220;IWM&#8221;.</div>
      <div style="text-align: justify; margin-top: 6pt;">Information from outside sources including, but not limited to the prospectus related to the IWM Fund and any other website referenced in this section, is not
        incorporated by reference in, and should not be considered part of, this document or any document incorporated herein by reference. We have not undertaken an independent review or due diligence of any publicly available information with respect to
        the IWM Fund or the target index.</div>
      <div style="text-align: justify; margin-top: 6pt;">Information filed by iShares with the SEC, including the prospectus for the IWM Fund, can be found by reference to its SEC file numbers: 333-92935 and 811-09729 or
        its CIK Code: 0001100663.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">18</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-weight: bold; text-align: justify;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of IWM from December 17, 2015 through December 17, 2025. The dotted lines represent its Call Threshold Value of
        $247.24, which is equal to 100.00% of its Initial Value, and its Contingent Interest Barrier Value and Barrier Value of $160.706, which is equal to 65.00% of its Initial Value.</div>
      <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Russell 2000 ETF (IWM)</div>
      <div style="text-align: center; margin-bottom: 6pt;"><img src="image00004.jpg"></div>
      <div style="font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">19</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z3b4727a63e494449b07539e7e47cbf43" style="border-collapse: collapse; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

          <tr>
            <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="font-weight: bold;">Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">We have derived all information contained herein regarding the Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 (the &#8220;QQQ Trust&#8221;) and the target index, as defined below,
        from publicly available information. Such information reflects the policies of, and is subject to changes by, the sponsor of the QQQ Trust, Invesco Capital Management LLC (the &#8220;sponsor&#8221; or its &#8220;investment adviser&#8221;), the trustee of the QQQ Trust,
        The Bank of New York Mellon (the &#8220;trustee&#8221;), and the index sponsor of the target index, as defined below.</div>
      <div style="text-align: justify; margin-top: 6pt;">The QQQ Trust is a unit investment trust that issues securities called &#8220;Trust Units&#8221; as &#8220;Units&#8221; of the QQQ Trust, each of which represents a fractional undivided
        ownership interest in the QQQ Trust. The QQQ Trust holds all the component securities of the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (the &#8220;target index&#8221;), and is rebalanced quarterly and reconstituted annually. The target index includes 100 of the largest
        domestic and international nonfinancial companies listed on the Nasdaq Stock Market based on market capitalization. The target index reflects companies across major industry groups including computer hardware and software, telecommunications,
        retail/wholesale trade and biotechnology. It does not contain securities of financial companies including investment companies. The target index is calculated, maintained and published by, Nasdaq, Inc. (the &#8220;index sponsor&#8221;). The index sponsor is
        under no obligation to continue to publish, and may discontinue or suspend the publication of, the target index at any time.</div>
      <div style="text-align: justify; margin-top: 6pt;">The QQQ Trust is not actively managed. The QQQ Trust holds a portfolio of securities consisting of substantially all of the component common stocks, in
        substantially the same weighting, which comprise the target index. The trustee on a nondiscretionary basis adjusts the composition of the QQQ Trust to conform to changes in the composition and/or weighting of securities in the target index.
        Although the QQQ Trust may fail to own certain securities included in the target index at any particular time, the QQQ Trust generally will be substantially invested in the securities included in the target index. The QQQ Trust may or may not hold
        all of the securities that are included in the target index.</div>
      <div style="text-align: justify; margin-top: 6pt;">Select information regarding the QQQ Trust&#8217;s expense ratio and its top constituents, country, industry and/or sector weightings may be made available on the QQQ
        Trust&#8217;s website. Expenses of the QQQ Trust reduce the net asset value of the assets held by the QQQ Trust and, therefore, reduce the value of the shares of the QQQ Trust.</div>
      <div style="text-align: justify; margin-top: 6pt;">Shares of the QQQ Trust are listed on the Nasdaq Stock Market under the ticker symbol &#8220;QQQ&#8221;.</div>
      <div style="text-align: justify; margin-top: 6pt;">Information from outside sources including, but not limited to the prospectus related to the QQQ Trust and any other website referenced in this section, is not
        incorporated by reference in, and should not be considered part of, this document or any document incorporated herein by reference. We have not undertaken an independent review or due diligence of any publicly available information with respect to
        the QQQ Trust or the target index.</div>
      <div style="text-align: justify; margin-top: 6pt;">Information filed by the QQQ Trust with the SEC, including the prospectus for the QQQ Trust, can be found by reference to its SEC file numbers: 333-61001 and
        811-08947 or its CIK Code: 0001067839.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">20</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-weight: bold; text-align: justify;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of QQQ from December 17, 2015 through December 17, 2025. The dotted lines represent its Call Threshold Value of
        $600.41, which is equal to 100.00% of its Initial Value, and its Contingent Interest Barrier Value and Barrier Value of $390.2665, which is equal to 65.00% of its Initial Value.</div>
      <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">Invesco QQQ Trust<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>, Series 1 (QQQ)</div>
      <div style="text-align: center; margin-bottom: 6pt;"><img src="image00005.jpg"></div>
      <div style="font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">21</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z76815df6d8a5433cbdb4fa8bd4ebbc27" style="border-collapse: collapse; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

          <tr>
            <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">We have derived all information contained herein regarding the SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust (the &#8220;SPY Trust&#8221;) and the target index, as
        defined below, from publicly available information. Such information reflects the policies of, and is subject to changes by, the sponsor of the SPY Trust, PDR Services LLC (the &#8220;sponsor&#8221; or its &#8220;investment adviser&#8221;), the trustee of the SPY Trust,
        State Street Global Advisors Trust Company (the &#8220;trustee&#8221;) or its parent company, State Street Bank and Trust Company, and the index sponsor of the target index, as defined below.</div>
      <div style="text-align: justify; margin-top: 6pt;">The SPY Trust is a unit investment trust that issues securities called &#8220;Units&#8221; of the SPY Trust, each of which represents a fractional undivided ownership interest
        in the SPY Trust. The SPY Trust seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (the &#8220;target index&#8221;). The target index is designed to
        measure the performance of 500 large-capitalization companies in the U.S. equity market. The target index is calculated, maintained and published by, S&amp;P Dow Jones Indices LLC (the &#8220;index sponsor&#8221;). The index sponsor is under no obligation to
        continue to publish, and may discontinue or suspend the publication of, the target index at any time.</div>
      <div style="text-align: justify; margin-top: 6pt;">The SPY Trust is not actively managed. The SPY Trust holds a portfolio of securities consisting of substantially all of the component common stocks, in
        substantially the same weighting, which comprise the target index. The trustee on a nondiscretionary basis adjusts the composition of the SPY Trust to conform to changes in the composition and/or weighting of securities in the target index.
        Although the SPY Trust may fail to own certain securities included in the target index at any particular time, the SPY Trust generally will be substantially invested in the securities included in the target index. The SPY Trust may or may not hold
        all of the securities that are included in the target index.</div>
      <div style="text-align: justify; margin-top: 6pt;">Select information regarding the SPY Trust&#8217;s expense ratio and its top constituents, country, industry and/or sector weightings may be made available on the SPY
        Trust&#8217;s website. Expenses of the SPY Trust reduce the net asset value of the assets held by the SPY Trust and, therefore, reduce the value of the shares of the SPY Trust.</div>
      <div style="text-align: justify; margin-top: 6pt;">Shares of the SPY Trust are listed on the NYSE Arca under the ticker symbol &#8220;SPY&#8221;.</div>
      <div style="text-align: justify; margin-top: 6pt;">Information from outside sources including, but not limited to the prospectus related to the SPY Trust and any other website referenced in this section, is not
        incorporated by reference in, and should not be considered part of, this document or any document incorporated herein by reference. We have not undertaken an independent review or due diligence of any publicly available information with respect to
        the SPY Trust or the target index.</div>
      <div style="text-align: justify; margin-top: 6pt;">Information filed by the SPY Trust with the SEC, including the prospectus for the SPY Trust, can be found by reference to its SEC file numbers: 033-46080 and
        811-06125 or its CIK Code: 0000884394.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">22</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-weight: bold; text-align: justify;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of SPY from December 17, 2015 through December 17, 2025. The dotted lines represent its Call Threshold Value of
        $671.40, which is equal to 100.00% of its Initial Value, and its Contingent Interest Barrier Value and Barrier Value of $436.41, which is equal to 65.00% of its Initial Value.</div>
      <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">SPDR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> ETF Trust (SPY)</div>
      <div style="text-align: center; margin-bottom: 6pt;"><img src="image00006.jpg"></div>
      <div style="font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">23</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 8pt; color: #00B050; font-size: 16pt;">Material U.S. Federal Income Tax Consequences</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The U.S. federal income tax consequences of your investment in the Notes are uncertain. No statutory, regulatory, judicial or administrative
        authority directly discusses the characterization for U.S. federal income tax purposes of securities with terms that are substantially the same as the Notes. Some of these tax consequences are summarized below, but we urge you to read the more
        detailed discussion under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the product supplement and to discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code
        of 1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed U.S. Department of the Treasury (the &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change,
        possibly with retroactive effect. This discussion applies to you only if you are a U.S. holder, as defined in the product supplement. An investment in the Notes is not appropriate for non-U.S. holders and we will not attempt to ascertain the tax
        consequences to non-U.S. holders of the purchase, ownership or disposition of the Notes. Tax consequences under state, local and non-U.S. laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as
        to the U.S. federal income tax consequences of your investment in the Notes, and the following discussion is not binding on the IRS.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">U.S. Tax Treatment.</font> Pursuant to the terms of the Notes, TD and you agree, in the
        absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to treat the Notes as prepaid derivative contracts with respect to the Reference Assets. If your Notes are so treated, any Contingent
        Interest Payments paid on the Notes (including any Contingent Interest Payments paid with respect to a Call Payment Date or on the Maturity Date) would be treated as ordinary income includable in income by you in accordance with your regular method
        of accounting for U.S. federal income tax purposes. Holders are urged to consult their tax advisors concerning the significance, and the potential impact, of the above considerations.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Upon the taxable disposition (including cash settlement) of a Note, you generally should recognize gain or loss equal to the difference between the amount
        realized on such taxable disposition (adjusted for amounts or proceeds attributable to any accrued and unpaid Contingent Interest Payments, which would be treated as ordinary income) and your tax basis in the Note. Your tax basis in a Note
        generally should equal your cost for the Note. Subject to the &#8220;constructive ownership&#8221; rules of Section 1260 of the Code, discussed below, such gain or loss should generally be long-term capital gain or loss if you have held your Notes for more
        than one year (otherwise such gain or loss should be short-term capital gain or loss if held for one year or less).<font style="font-size: 8pt;">&#160;</font>The deductibility of capital losses is subject to limitations. Although
        uncertain, it is possible that proceeds received from the sale or exchange of your Notes prior to a Contingent Interest Payment Date, but that could be attributed to an expected Contingent Interest Payment, could be treated as ordinary income. You
        should consult your tax advisor regarding this risk.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel,
          Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be reasonable to treat your Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes,
          it is possible that your Notes could alternatively be treated for tax purposes as a single contingent payment debt instrument, or pursuant to some other characterization (including possible treatment as a &#8220;constructive ownership transaction&#8221;
          under Section 1260 of the Code)</font><font style="font-size: 8pt;">,</font><font style="font-weight: bold;"> such that the timing and character of your income from the Notes could differ
          materially and adversely from the treatment described above, as described further under &#8220;Material U.S. Federal Income Tax Consequences &#8211; Alternative Treatments&#8221; in the product supplement.</font></div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Section 1260</font>. Because each Reference Asset issuer would be treated as a &#8220;pass-thru
        entity&#8221; for purposes of Section 1260 of the Code, it is possible that an investment in the Notes could be treated as a &#8220;constructive ownership transaction&#8221; within the meaning of Section 1260 of the Code. If the Notes were treated as a constructive
        ownership transaction certain adverse U.S. federal income tax consequences could apply (i.e., all or a portion of any long-term capital gain that you recognize upon the taxable disposition of your Notes could be recharacterized as ordinary income
        and you could be subject to an interest charge on deferred tax liability with respect to such recharacterized gain). We urge you to read the discussion concerning the possible treatment of the Notes as a constructive ownership transaction under
        &#8220;Material U.S. Federal Income Tax Consequences &#8211; Section 1260&#8221; in the product supplement.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Except to the extent otherwise required by law, TD intends to treat your Notes for U.S. federal income tax purposes in accordance with the treatment described
        above and under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of
        holders of the Notes. According to Notice 2008-2, the IRS and the Treasury are considering whether the holder of an instrument such as the Notes should be required to accrue ordinary income on a current basis. It is not possible to determine what
        guidance they will ultimately issue, if any. It is possible, however, that under such guidance, holders of the Notes will ultimately be required to accrue current income, possibly in excess of any Contingent Interest Payments received by such
        holders, and this could be applied on a retroactive basis. According to the Notice, the IRS and the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary
        or capital and whether the special &#8220;constructive ownership rules&#8221; of Section 1260 of the Code, discussed above,<font style="font-size: 8pt;">&#160;</font>should be applied to such instruments. You are urged to consult your tax
        advisor concerning the significance, and the potential impact, of the above considerations.</div>
      <div style="text-align: justify;"><font style="font-style: italic;">Medicare Tax on Net Investment Income. </font>U.S. holders that are individuals, estates or certain trusts
        are subject to an additional 3.8% tax on all or a portion of their &#8220;net investment income&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the Notes, to the
        extent of their net investment income or undistributed net investment income (as the case may be) that when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a
        joint return (or a surviving spouse), $125,000 for a married individual filing a separate</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">24</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt;">return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the
        income tax. You should consult your tax advisor as to the consequences of the 3.8% Medicare tax.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Specified Foreign Financial Assets. </font>U.S. holders may be subject to reporting
        obligations with respect to their Notes if they do not hold their Notes in an account maintained by a financial institution and the aggregate value of their Notes and certain other &#8220;specified foreign financial assets&#8221; (applying certain attribution
        rules) exceeds an applicable threshold. Significant penalties can apply if a U.S. holder is required to disclose its Notes and fails to do so.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Backup Withholding and Information Reporting.</font> The proceeds received from a taxable
        disposition of the Notes will be subject to information reporting unless you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as
        an accurate taxpayer number, if you are a U.S. holder) or meet certain other conditions.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Proposed Legislation. </font>In 2007, legislation was introduced in Congress that, if it
        had been enacted, would have required holders of Notes purchased after the bill was enacted to accrue interest income over the term of the Notes despite the fact that there may be no interest payments over the term of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been
        enacted, the effect of this legislation generally would have been to require instruments such as the Notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">It is impossible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of
        your Notes. You are urged to consult your tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Notes.</div>
      <div style="font-weight: bold; text-align: justify;">You are urged to consult your tax advisor concerning the application of U.S. federal income tax laws to an investment in the Notes, as well as any tax
        consequences of the purchase, beneficial ownership and disposition of the Notes arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of TD).</div>
      <div style="text-align: justify;"><font style="font-weight: bold;"> </font><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">25</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="color: #00B050; font-size: 16pt; text-align: justify;">Supplemental Plan of Distribution (Conflicts of Interest)</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">We have appointed TDS, an affiliate of TD, as the Agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, TDS will
        purchase the Notes from TD at the public offering price less the underwriting discount specified on the cover page hereof and will use all of that commission to allow selling concessions to other registered broker-dealers in connection with the
        distribution of the Notes. The underwriting discount represents the selling concessions for other dealers in connection with the distribution of the Notes. The Notes were generally offered to the public at the public offering price, provided that
        certain fee based advisory accounts may have agreed to purchase the Notes for as low as the price specified on the cover hereof and such registered broker-dealers may have agreed to forgo, in their sole discretion, some or all of their selling
        concessions in connection with such sales. TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Conflicts of Interest. </font>TDS is an affiliate of TD and, as such, has a &#8216;&#8216;conflict of
        interest&#8217;&#8217; in this offering within the meaning of Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. If any other affiliate of TD participates in this offering, that affiliate will also have a &#8220;conflict of interest&#8221; within the
        meaning of FINRA Rule 5121. In addition, TD will receive the net proceeds from the initial public offering of the Notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. This offering of the Notes will be
        conducted in compliance with the provisions of FINRA Rule 5121. In accordance with FINRA Rule 5121, neither TDS nor any other affiliate of ours is permitted to sell the Notes in this offering to an account over which it exercises discretionary
        authority without the prior specific written approval of the account holder.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">We, TDS, another of our affiliates or third parties may use this pricing supplement in the initial sale of the Notes. In addition, we, TDS, another of our
        affiliates or third parties may use this pricing supplement in a market-making transaction in the Notes after their initial sale. <font style="font-weight: bold; font-style: italic;">If a purchaser buys the
          Notes from us, TDS, another of our affiliates or third parties, this pricing supplement is being used in a market-making transaction unless we, TDS, another of our affiliates or third parties informs such purchaser otherwise in the confirmation
          of sale.</font></div>
      <div style="text-align: justify; margin-top: 3pt; font-weight: bold;">Prohibition on Sales to EEA Retail Investors</div>
      <div style="text-align: justify; margin-top: 3pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in
        the European Economic Area (the &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); (ii) a customer
        within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as
        amended. Consequently no key information document required by Regulation (EU) No 1286/2014 (the &#8220;EU PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and
        therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</div>
      <div style="text-align: justify; margin-top: 3pt; font-weight: bold;">Prohibition on Sales to United Kingdom Retail Investors</div>
      <div style="text-align: justify; margin-top: 3pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in
        the United Kingdom (&#8220;UK&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the
        European Union (Withdrawal) Act 2018 (the &#8220;EUWA&#8221;); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the &#8220;FSMA&#8221;) and any rules or regulations made under the FSMA to implement Directive (EU)
        2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document
        required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and
        therefore offering or selling the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">26</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="color: #00B050; font-size: 16pt; text-align: justify;">Additional Information Regarding the Estimated Value of the Notes</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">The final terms for the Notes were determined on the Strike Date, based on prevailing market conditions, and are specified elsewhere in this
        pricing supplement.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The economic terms of the Notes are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks and
        our appetite for borrowing), and several factors, including any sales commissions expected to be paid to TDS or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated
        intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection with structuring the Notes, estimated costs which we may incur in connection with the Notes and the estimated cost which we may incur in hedging our
        obligations under the Notes. Because our internal funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the
        levels at which our benchmark debt securities trade in the secondary market is expected to have had an adverse effect on the economic terms of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">On the cover page of this pricing supplement, we have provided the estimated value for the Notes. The estimated value was determined by reference to our
        internal pricing models which take into account a number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates),
        price-sensitivity analysis, time to maturity of the Notes and our internal funding rate. For more information about the estimated value, see &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; herein. Because our internal
        funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt securities trade
        in the secondary market is expected, assuming all other economic terms are held constant, to increase the estimated value of the Notes. For more information see the discussion under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and
        Liquidity &#8212; The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.&#8221;</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Our estimated value of the Notes is not a prediction of the price at which the Notes may trade in the secondary market, nor will it be the price at which the
        Agent may buy or sell the Notes in the secondary market. Subject to normal market and funding conditions, the Agent or another affiliate of ours intends to offer to purchase the Notes in the secondary market but it is not obligated to do so.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary
        market, if any, may exceed our estimated value on the Pricing Date for a temporary period expected to be approximately 3 months after the Issue Date because, in our discretion, we may elect to effectively reimburse to investors a portion of the
        estimated cost of hedging our obligations under the Notes and other costs in connection with the Notes which we will no longer expect to incur over the term of the Notes. We made such discretionary election and determined this temporary
        reimbursement period on the basis of a number of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated costs which we effectively reimburse to investors in this way
        may not be allocated ratably throughout the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Issue Date of the Notes based on changes in market conditions and
        other factors that cannot be predicted.</div>
      <div style="margin: 12pt 0px 0px; font-weight: bold; text-align: justify;">We urge you to read the &#8220;Additional Risk Factors&#8221; herein.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">27</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 6pt; color: #00B050; font-size: 16pt;">Validity of the Notes</div>
      <div style="text-align: justify; margin-top: 12pt; margin-bottom: 6pt;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special products counsel to TD, when the Notes offered by this pricing
        supplement have been executed and issued by TD and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the Notes will be valid and binding obligations of TD, enforceable against TD in
        accordance with their terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity
        (regardless of whether enforcement is sought in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law,
        Fried, Frank, Harris, Shriver &amp; Jacobson LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by McCarthy T&#233;trault LLP, Canadian legal counsel for TD, in its opinion expressed below. In addition,
        this opinion is subject to customary assumptions about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the Notes, authentication of the Notes and the genuineness of signatures and certain factual matters,
        all as stated in the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP filed as Exhibit 5.3 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div style="text-align: justify; margin-top: 12pt;">In the opinion of McCarthy T&#233;trault LLP, the issue and sale of the Notes has been duly authorized by all necessary corporate action on the part of TD, and when
        this pricing supplement has been attached to, and duly notated on, the master note that represents the Notes, the Notes will have been validly executed and issued and, to the extent validity of the Notes is a matter governed by the laws of the
        Province of Ontario, or the laws of Canada applicable therein, will be valid obligations of TD, subject to the following limitations: (i) the enforceability of the indenture is subject to bankruptcy, insolvency, reorganization, arrangement, winding
        up, moratorium and other similar laws of general application limiting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the fact that the availability of
        equitable remedies, such as injunctive relief and specific performance, is in the discretion of a court; (iii) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada; and (iv) the enforceability
        of the indenture will be subject to the limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the indenture to be unenforceable as an attempt to vary or
        exclude a limitation period under that Act. This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable thereto. In addition, this opinion is subject to: (i) the
        assumption that the senior indenture has been duly authorized, executed and delivered by, and constitutes a valid and legally binding obligation of, the trustee, enforceable against the trustee in accordance with its terms; and (ii) customary
        assumptions about the genuineness of signatures and certain factual matters all as stated in the letter of such counsel dated December 20, 2024, which has been filed as Exhibit 5.2 to the registration statement on Form F-3 filed by TD on December
        20, 2024.</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <div style="width: 100%;" class="BRPFPageFooter">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top;">
                  <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50%; vertical-align: top;">
                  <div style="text-align: right; font-size: 8pt;">P-<font class="BRPFPageNumber">28</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Dec 19 14:13:21 UTC 2025 -->
<!--?xml version="1.0" encoding="ASCII"?-->
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 04 23:02:01 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->



<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: Arial; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);"><div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-bottom: 20px;">

      <div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;">Calculation of Filing Fee Tables</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-32">F-3</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-33">TORONTO DOMINION BANK</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 12pt; font-weight: bold;">Narrative Disclosure</div>
        <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>

        <ix:nonNumeric contextRef="c0" escape="true" name="ffd:NrrtvDsclsr" id="ixv-26"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-34">1,400,000.00</ix:nonFraction></span>. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-35">final prospectus</ix:nonNumeric> for the related offering.</div></ix:nonNumeric><div><br/>
        </div>
      </div>
    </div>
  </div></div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-38">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-39">0000947263</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-40">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OfferingTableNa" id="ixv-41">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-42">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-43">333-283969</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-44">424B2</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000947263</xbrli:identifier>
  </xbrli:entity>
<!-- [WMV6][57GJiJYRbIAufgdectk5UHZ3uXDSFe5SMmtTWZttcYpwDitop8rZHTEoN5Ow5i6uS9jcuvLQwG73pXGqxoEdpd1ITH5YBZLgwMm/1hqxeyB3/3wv+XSNQvrybOv2JQymKuXS/VyQaE7plCVsAFYiJRu/0oVpwPoJWzPGl1d/XqJ4Y8FA8Iunm3eRwm5IGavlN/CLf/X327x+qNklwsHHHy/q4l6gGX6jlyV7biBv9BuYH8mGdPgqlKhW/6nQCqzdSR91rvbYzrRqwWF2Bmol1B7bUA/4/LFaAOcHuctkSUsKAE6f6knALPAPN/08beHwqpFafT2lSbHqVttf7buK0fbENkJnoBqtdqm1agDAm6uD6cy09m48H4wSxWuA45q8ZpPMHjvNXKtXWQbVGHSp3e3QT6ivkHiI2+X3n2gV] CSR-->
  <xbrli:period>
    <xbrli:startDate>2025-12-18</xbrli:startDate>
    <xbrli:endDate>2025-12-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) %$# 2(  A$! Q$!_\0
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MVO/^C5OVD/\ PQWQ._\ F7KL_L+//^A-FO\ X;L7_P#*3U_]2.-/^B0XH_\
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M_%.'_J\O_G//_P >3_-_HK_2 HH_XEG_ .JV_P#-;_\ P\'_ !3A_P"KR_\
(G//_ ,>3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &  CP# 2(  A$! Q$!_\0
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M0G^-'_"2:)_T%]/_ / A/\: -:BLG_A)-$_Z"^G_ /@0G^-'_"2:)_T%]/\
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MH UJ*R?^$DT3_H+Z?_X$)_C1_P ))HG_ $%]/_\  A/\: -:BLG_ (231/\
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M[_P&3_"M6B@#*_X1S1/^@/IW_@,G^%'_  CFB?\ 0'T[_P !D_PK5HH RO\
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M  CFB?\ 0'T[_P !D_PK5HH RO\ A'-$_P"@/IW_ (#)_A1_PCFB?] ?3O\
MP&3_  K5HH RO^$<T3_H#Z=_X#)_A1_PCFB?] ?3O_ 9/\*U:* ,K_A'-$_Z
M ^G?^ R?X4?\(YHG_0'T[_P&3_"M6B@#*_X1S1/^@/IW_@,G^%1W'AS1!!)_
MQ*-/^Z?^79/3Z5LU'<?\>\G^Z?Y4 <U\*_\ DF?A7_L%VW_HM:ZFN6^%?_)-
M/"O_ &"[;_T6M=30 4444 %%%% !1110 4444 <I_P U2_[A'_M6NKKE/^:I
M?]PC_P!JUU= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1W'_ ![R?[I_
ME4E1W'_'O)_NG^5 '-?"O_DFGA7_ +!=M_Z+6NIKEOA7_P DT\*_]@NV_P#1
M:UU- !1110 4444 %%4M4U2STN)9+Z98E;.,@GIUJ&37M.CGAA-P&>9%DCV
ML&5ONG(['!H TZ*SI-;TZ+4EL)+J-;IB%V$_Q$9 SZD=JT: .4_YJE_W"/\
MVK75URG_ #5+_N$?^U:ZN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ$22>6;7]RQ_@/[OJ*-<C\4Z>+/['<^+;[SH1))Y9M?W+'^ _N^HKUBO.O\
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M+V^5]OB^[YOWL]/PKI?[;\4_]"D?_!C%2_\ -4O^X1_[5KJZ .3_ +;\4_\
M0I'_ ,&,5']M^*?^A2/_ (,8JZRB@#D_[;\4_P#0I'_P8Q4?VWXI_P"A2/\
MX,8JZRB@#D_[;\4_]"D?_!C%1_;?BG_H4C_X,8JZRB@#D_[;\4_]"D?_  8Q
M4?VWXI_Z%(_^#&*NLHH Y/\ MOQ3_P!"D?\ P8Q4?VWXI_Z%(_\ @QBKK**
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M3FOA7_R3/PK_ -@NV_\ 1:UU-<M\*_\ DFGA7_L%VW_HM:ZF@ HHHH ****
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M\5ZC=Z5I,EW9013&/E_-; 5?PZFJ&L:[/9:[':O+;6UH8HW\V='.]F9@5!'
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M6%X5_P"@U;?DW^%'_"PO"O\ T&K;\F_PKIO(B_YY)_WR*/(B_P">2?\ ?(H
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MM*C"D';Q^57O%AMK7PWJ4DB(H\AE!VCJ1@?J:UFE*<4NMC.#<8._2YC-X_\
M#]QIC))JEO#>218,66RKD?=SCKGBO/QJECI/V>;0+U9IYK?R[V( _NR0,CD>
MN:V;6]B\0:+HOA^TF\BZ8D3L4[*"1S[XKMO&.AIJ/AYK:UMD:X0IY1  *X(S
M^F:ZH6P\^6>S>WET.:=\1'FCNE^)R>A^(/#=AK45[)KEHJ+8I;>7AMP88SGC
MVKI_^%A>%?\ H-6WY-_A72);0JBCRH^!C[HIWD1?\\D_[Y%<,YN;NSMA!05D
M<S_PL+PK_P!!JV_)O\*/^%A>%?\ H-6WY-_A73>1%_SR3_OD4>1%_P \D_[Y
M%06<S_PL+PK_ -!JV_)O\*/^%A>%?^@U;?DW^%=-Y$7_ #R3_OD4>1%_SR3_
M +Y% ',_\+"\*_\ 0:MOR;_"C_A87A7_ *#5M^3?X5TWD1?\\D_[Y%'D1?\
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M9<L[MU9B<DUIT5C.M*<5%FL*,82<D%%%%9&P4444 %%%% &5XIC$OAS4E/\
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M-0HSZ"I*Y9.[;.F*LD@HHHI%!1110 4444 %%%% !1110 4V.-8U"QJJJ.@
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M>\2?^#%Z .MHKDO^$'A_Z#WB3_P8O1_P@\/_ $'O$G_@Q>@#K:*Y+_A!X?\
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M +5KJZY3_FJ7_<(_]JUU= !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1W
M'_'O)_NG^525'<?\>\G^Z?Y4 <U\*_\ DFGA7_L%VW_HM:ZFN6^%?_)-/"O_
M &"[;_T6M=30 4444 %%%% !1110 4444 <I_P U2_[A'_M6NKKE/^:I?]PC
M_P!JUU= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M )]M _[^2T>=XW_Y]M _[^2T =;17)>=XW_Y]M _[^2T>=XW_P"?;0/^_DM
M'6U'<?\ 'O)_NG^5<MYWC?\ Y]M _P"_DM,FF\;^3)FVT#&T_P#+27TH G^%
M?_)-/"O_ &"[;_T6M=37+?"O_DF?A7/_ $"[;_T6M=30 4444 %%%% !3&AC
M=U9XT9E^Z2H)%/HH 9Y2&02%%\P# ;'./K3Z** .4_YJE_W"/_:M=77*?\U2
M_P"X1_[5KJZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CN/^/>3_ '3_
M "J2H[C_ (]Y/]T_RH YKX5_\DT\*_\ 8+MO_1:UU-<M\*_^2:>%?^P7;?\
MHM:ZF@ HHHH **** "BBB@ HHHH Y3_FJ7_<(_\ :M=77*?\U2_[A'_M6NKH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=7_\%%U_\;J*'XD>'9S((7U.0QML?9I5T=K>A_=\&@#LJ*Y+_A8.A_W=7_\
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MD&W5_NG_ )A%UZ?]<Z )_A7_ ,DT\*_]@NV_]%K74URWPKY^&?A7_L%VQ_\
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M&>.">: (M$TJPU=/[1LOMUK87,RW3V;JJI+(,$/CDCD#H0#BNOI% 4 *  .
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M:-8#3;/R?,:61G:620C&]V))..W)Z4:/8+I^GVMON\V2&%(3*P^9PHQS5Z@
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M-G<66H21K'-!#C[/+N!3@D[EW  @X-;GAW1[BVB(U&.U !#+''^\S)DEI2Q
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M30Q-,XAPJ$G@;P.A&3A3[^E85O8ZMJ6KW,["S:XMYA%/')D(DRJ"DR<$L-K
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-44 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00005.jpg
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &  CP# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHHH **
MSM<N[RQM3<6D-K)'&K/*UQ.8@J@9R,*V>]8+>++P6+7)TI0+:U2ZO%,^#$K9
M.%^7YB ,G.* .OHKF9_$TB73O'9J^F1W,=I)<>;AP[[0"$QRH+ $YSUXKIJ
M"BHOM,'_ #VC_P"^A1]I@_Y[1?\ ?8H EHJ+[3!_SVB_[[%'VF#_ )[1?]]B
M@"6BHOM,'_/:+_OL4?:8/^>T7_?8H EHJ+[3!_SVB_[[%'VF#_GM%_WV* ):
M*B^TP?\ /:+_ +[%'VF#_GM%_P!]B@"6BHOM,'_/:+_OL4?:8/\ GM%_WV*
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M'_/:+_OL4?:8/^>T7_?8H EHJ+[3!_SVB_[[%'VF#_GM%_WV* ):*B^TP?\
M/:+_ +[%'VF#_GM%_P!]B@"6BHOM,'_/:+_OL4?:8/\ GM%_WV* ):*B^TP?
M\]HO^^Q1]I@_Y[1?]]B@"6B@'(R.110 4444 %%%% &?KFF_VK9+:M,8X6D5
MI@%SYB Y*>P.,'VS69K'AR6^NKQH+X6]M?PK!=Q&+<649'R-D;202.AKHZ*
M.:D\,,UU(BWH73);E+M[;RLMO7:0 ^>%RH.,>O-=*1D8-%% 'F1\$>%3\2/L
MY\-Z-Y']E^9Y?V*/;N\W&[&,9]ZZ;_A7W@[_ *%70O\ P B_^)J/_FJ7_<(_
M]JUU= ',?\*^\'?]"KH7_@!%_P#$T?\ "OO!W_0JZ%_X 1?_ !-=/10!S'_"
MOO!W_0JZ%_X 1?\ Q-'_  K[P=_T*NA?^ $7_P 373T4 <Q_PK[P=_T*NA?^
M $7_ ,31_P *^\'?]"KH7_@!%_\ $UT]% ',?\*^\'?]"KH7_@!%_P#$T?\
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M\'?]"KH7_@!%_P#$T?\ "OO!W_0JZ%_X 1?_ !-=/10!S'_"OO!W_0JZ%_X
M1?\ Q-'_  K[P=_T*NA?^ $7_P 373T4 <Q_PK[P=_T*NA?^ $7_ ,31_P *
M^\'?]"KH7_@!%_\ $UT]% ',?\*^\'?]"KH7_@!%_P#$T?\ "OO!W_0JZ%_X
M 1?_ !-=/10!S'_"OO!W_0JZ%_X 1?\ Q-'_  K[P=_T*NA?^ $7_P 373T4
M <Q_PK[P=_T*NA?^ $7_ ,31_P *^\'?]"KH7_@!%_\ $UT]% ',?\*^\'?]
M"KH7_@!%_P#$T?\ "OO!W_0JZ%_X 1?_ !-=/10!S'_"OO!W_0JZ%_X 1?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ J.X_X]Y/\ =/\ *I*P]-UN+4;'5)7VQ1VLTD!8
MG@A>]4HMJZ)<DG9E+X5_\DT\*_\ 8+MO_1:UU-<M\*_^2:>%?^P7;?\ HM:Z
MFI*"BBB@ HHHH CGFBMXS)/(D:#JSG %1M>VR^5NN(AYW^KRX^?Z>M<SXZC=
MKW29)',=C&TAD?R/."OM&PE?^^AGWKF[E9KBQU!=5TYO[1O+"..P"VY&&&[
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MM*VC"BBBD 4444 %%%% !1110!RG_-4O^X1_[5KJZY3_ )JE_P!PC_VK75T
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M+C_42?[I_E61J<S\*^?AGX5_[!=M_P"BUKJ:Y;X5_P#)-/"O_8+MO_1:UU-
M!1110 4444 %%%% !1110!RG_-4O^X1_[5KJZY3_ )JE_P!PC_VK75T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVZ9;C(.<_NUKJ*Y;X5_\DT\*_P#8+MO_ $6M=35G,[7T"BBB@04444 %%%%
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MT >I45YS=7)>\N+M[B1=:BU.""*$2D$1$Q@KL[J59B3C^5>C'I0!RG_-4O\
MN$?^U:ZNO+3KVN?\+&\W_A%+KS?[,V^7]KB^[YOWL_I72_\ "1^(?^A/N_\
MP,B_QH ZVBN2_P"$C\0_]"?=_P#@9%_C1_PD?B'_ *$^[_\  R+_ !H ZVBN
M2_X2/Q#_ -"?=_\ @9%_C1_PD?B'_H3[O_P,B_QH ZVBN2_X2/Q#_P!"?=_^
M!D7^-'_"1^(?^A/N_P#P,B_QH ZVBN2_X2/Q#_T)]W_X&1?XT?\ "1^(?^A/
MN_\ P,B_QH ZVBN2_P"$C\0_]"?=_P#@9%_C1_PD?B'_ *$^[_\  R+_ !H
MZVBN2_X2/Q#_ -"?=_\ @9%_C1_PD?B'_H3[O_P,B_QH ZVBN2_X2/Q#_P!"
M?=_^!D7^-'_"1^(?^A/N_P#P,B_QH ZVBN2_X2/Q#_T)]W_X&1?XT?\ "1^(
M?^A/N_\ P,B_QH ZVBN2_P"$C\0_]"?=_P#@9%_C1_PD?B'_ *$^[_\  R+_
M !H ZVBN2_X2/Q#_ -"?=_\ @9%_C1_PD?B'_H3[O_P,B_QH ZVBN2_X2/Q#
M_P!"?=_^!D7^-'_"1^(?^A/N_P#P,B_QH ZVBN2_X2/Q#_T)]W_X&1?XT?\
M"1^(?^A/N_\ P,B_QH ZVBN2_P"$C\0_]"?=_P#@9%_C1_PD?B'_ *$^[_\
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M$T&N^%[D!AB<0N0>.2./YU;_ .$C\0_]"?=_^!D7^-8OBW6]:N-&=KCPW<6
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M#(O\:/\ A(_$/_0GW?\ X&1?XT =;17)?\)'XA_Z$^[_ / R+_&C_A(_$/\
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M "BBB@ HHHH **** "BBB@ J.X_X]Y/]T_RJ2H[C_CWD_P!T_P J .:^%?\
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M.:M4JLU.5XJRZ#I0<(^]JPHHHK(U"BBB@ HHHH **** "BBB@ HHHH ****
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MRO[*W;?)&,^;UKJ/^$2\/?\ 0%T__OPO^% %G^WM'_Z"NG_^!*?XT?V]H_\
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MD@\[2+%Y/+7<S0J23CDFMJDG&FI?S67W&-.*E4<?Y6W]YH?V]H__ $%=/_\
M E/\:/[>T?\ Z"NG_P#@2G^-5O\ A$O#W_0%T_\ [\+_ (4?\(EX>_Z NG_]
M^%_PKC.PL_V]H_\ T%=/_P# E/\ &C^WM'_Z"NG_ /@2G^-5O^$2\/?] 73_
M /OPO^%'_")>'O\ H"Z?_P!^%_PH L_V]H__ $%=/_\  E/\:/[>T?\ Z"NG
M_P#@2G^-5O\ A$O#W_0%T_\ [\+_ (4?\(EX>_Z NG_]^%_PH L_V]H__05T
M_P#\"4_QH_M[1_\ H*Z?_P"!*?XU6_X1+P]_T!=/_P"_"_X4?\(EX>_Z NG_
M /?A?\* +/\ ;VC_ /05T_\ \"4_QH_M[1_^@KI__@2G^-5O^$2\/?\ 0%T_
M_OPO^%'_  B7A[_H"Z?_ -^%_P * +/]O:/_ -!73_\ P)3_ !H_M[1_^@KI
M_P#X$I_C5;_A$O#W_0%T_P#[\+_A1_PB7A[_ * NG_\ ?A?\* +/]O:/_P!!
M73__  )3_&C^WM'_ .@KI_\ X$I_C5;_ (1+P]_T!=/_ ._"_P"%'_")>'O^
M@+I__?A?\* +/]O:/_T%=/\ _ E/\:/[>T?_ *"NG_\ @2G^-5O^$2\/?] 7
M3_\ OPO^%'_")>'O^@+I_P#WX7_"@"S_ &]H_P#T%=/_ / E/\:/[>T?_H*Z
M?_X$I_C5;_A$O#W_ $!=/_[\+_A1_P (EX>_Z NG_P#?A?\ "@"S_;VC_P#0
M5T__ ,"4_P :/[>T?_H*Z?\ ^!*?XU6_X1+P]_T!=/\ ^_"_X4?\(EX>_P"@
M+I__ 'X7_"@"S_;VC_\ 05T__P "4_QH_M[1_P#H*Z?_ .!*?XU6_P"$2\/?
M] 73_P#OPO\ A1_PB7A[_H"Z?_WX7_"@"S_;VC_]!73_ /P)3_&C^WM'_P"@
MKI__ ($I_C5;_A$O#W_0%T__ +\+_A1_PB7A[_H"Z?\ ]^%_PH L_P!O:/\
M]!73_P#P)3_&C^WM'_Z"NG_^!*?XU6_X1+P]_P! 73_^_"_X4?\ ")>'O^@+
MI_\ WX7_  H L_V]H_\ T%=/_P# E/\ &C^WM'_Z"NG_ /@2G^-5O^$2\/?]
M 73_ /OPO^%'_")>'O\ H"Z?_P!^%_PH L_V]H__ $%=/_\  E/\:/[>T?\
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M*+Z$1@HMR74****@L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *CN/^/>3_=/\JDJ.X_X]Y/]
MT_RH YKX5_\ )-/"O_8+MO\ T6M=37+?"O\ Y)IX5_[!=M_Z+6NIH **** "
MBBB@ HILDB1(7D940=68X IDMQ!%)&DLT:/(<(K, 6/MZT 2T5$UQ"MPL#31
MB=AN$98;B/7'6I: .4_YJE_W"/\ VK75UQFJW46F?$2TNKEOW=Q8_9AC^%O,
MSD^@[5V><=:;BTDWU)4DVTN@45DP^(-*FOS917T+7(_@!_KTH/B+21)<H;^
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MO_B* .JHKDY?B)X6B7=+J91<A<M;2@9)P!]WJ3Q3O^%@>&O^@A)_X"S?_$4
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M#>6T=Q;2++#(-R.IR"* )/+3^ZOY4>6G]U?RIU% #?+3^ZOY4>6G]U?RIU%
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MH>E:&CZ59Z-8I9Z="(8$Z ')/N2>35BVMH;9"L$21@G<=BA<GUXJ6@ HHHH
M*IZEJ$%BF))81<.#Y,3R!3*P'09ZUF:]J=W%JEGIMH\5HUTK%;JX0NA(_@4
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MM,LH[2QB$4$8PJC^9/<^]6J** "BBN=U?4KYM<BTJRD@LG>+S4N+B,N)3W1
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>V8O+-(<O*YZLQ]:NT44 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00006.jpg
<TEXT>
begin 644 image00006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &  CP# 2(  A$! Q$!_\0
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M %%9/_"2:)_T%]/_ / A/\:/^$DT3_H+Z?\ ^!"?XT :U%9/_"2:)_T%]/\
M_ A/\:/^$DT3_H+Z?_X$)_C0!K45D_\ "2:)_P!!?3__  (3_&C_ (231/\
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M_A)-$_Z"^G_^!"?XT :U%9/_  DFB?\ 07T__P "$_QH_P"$DT3_ *"^G_\
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M_P! ?3O_  &3_"C_ (1S1/\ H#Z=_P" R?X5JT4 97_".:)_T!]._P# 9/\
M"C_A'-$_Z ^G?^ R?X5JT4 97_".:)_T!]._\!D_PH_X1S1/^@/IW_@,G^%:
MM% &5_PCFB?] ?3O_ 9/\*/^$<T3_H#Z=_X#)_A6K10!E?\ ".:)_P! ?3O_
M  &3_"C_ (1S1/\ H#Z=_P" R?X5JT4 97_".:)_T!]._P# 9/\ "C_A'-$_
MZ ^G?^ R?X5JT4 97_".:)_T!]._\!D_PH_X1S1/^@/IW_@,G^%:M% &5_PC
MFB?] ?3O_ 9/\*/^$<T3_H#Z=_X#)_A6K10!E?\ ".:)_P! ?3O_  &3_"C_
M (1S1/\ H#Z=_P" R?X5JT4 97_".:)_T!]._P# 9/\ "C_A'-$_Z ^G?^ R
M?X5JT4 97_".:)_T!]._\!D_PH_X1S1/^@/IW_@,G^%:M% &5_PCFB?] ?3O
M_ 9/\*/^$<T3_H#Z=_X#)_A6K10!E?\ ".:)_P! ?3O_  &3_"C_ (1S1/\
MH#Z=_P" R?X5JT4 97_".:)_T!]._P# 9/\ "C_A'-$_Z ^G?^ R?X5JT4 9
M7_".:)_T!]._\!D_PH_X1S1/^@/IW_@,G^%:M% &5_PCFB?] ?3O_ 9/\*/^
M$<T3_H#Z=_X#)_A6K10!E?\ ".:)_P! ?3O_  &3_"C_ (1S1/\ H#Z=_P"
MR?X5JT4 97_".:)_T!]._P# 9/\ "C_A'-$_Z ^G?^ R?X5JT4 97_".:)_T
M!]._\!D_PH_X1S1/^@/IW_@,G^%:M% &5_PCFB?] ?3O_ 9/\*/^$<T3_H#Z
M=_X#)_A6K10!E?\ ".:)_P! ?3O_  &3_"C_ (1S1/\ H#Z=_P" R?X5JT4
M97_".:)_T!]._P# 9/\ "C_A'-$_Z ^G?^ R?X5JT4 97_".:)_T!]._\!D_
MPJ.X\.:(()/^)1I_W3_R[)Z?2MFH[C_CWD_W3_*@#FOA7_R3/PK_ -@NV_\
M1:UU-<M\*_\ DFGA7_L%VW_HM:ZF@ HHHH **** "BBB@ HHHH Y3_FJ7_<(
M_P#:M=77*?\ -4O^X1_[5KJZ "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*CN/^/>3_=/\JDJ.X_X]Y/\ =/\ *@#FOA7_ ,DT\*_]@NV_]%K74URWPK_Y
M)IX5_P"P7;?^BUKJ: "BBB@ HHHH P_%Y2'29+IYKF-HAB-()-AD=L!5]\G
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M]G'L"Q596M-Z;:LY_4O!WA[5!;B_TFVG%O$(8MP/R(.BCVHU+P=X>U06XO\
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MX<^&'<Y=M,MR3ZGRQ73URWPK_P"2:>%?^P7;?^BUKJ:YRFVW=A1110 4444
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MS?&?_0Q:5_X*V_\ CM '6T5R7]F^,_\ H8M*_P#!6W_QVC^S?&?_ $,6E?\
M@K;_ ..T =;17)?V;XS_ .ABTK_P5M_\=H_LWQG_ -#%I7_@K;_X[0!UM%<E
M_9OC/_H8M*_\%;?_ !VC^S?&?_0Q:5_X*V_^.T =;17)?V;XS_Z&+2O_  5M
M_P#':/[-\9_]#%I7_@K;_P".T =;17)?V;XS_P"ABTK_ ,%;?_':/[-\9_\
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MADTXNR9YP6\P9/OBB/-2I\RT;_()<M6?*]E^9W51W'_'O)_NG^5<M_9OC/\
MZ&+2O_!6W_QVF3:;XR$,F?$6E?=/_,+/I_UUKG.@G^%?_)-/"O\ V"[;_P!%
MK74URWPK_P"29^%?^P7;?^BUKJ: "BBB@ HHHH **** "BBB@#E/^:I?]PC_
M -JUU=<I_P U2_[A'_M6NKH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG^U[?R?[+\O=AOO>;G'2NE_X6%X5_P"@U;?DW^%1>3'_ ,+1QY:8_LG^Z/\
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M2- @^4= *ZG?"I<KU9RJV)?O+1'(Z?XM\$Z=),]GJMI$9=H8*&Q\HP.U7O\
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M]JUU=<I_S5+_ +A'_M6NKH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M110 4444 %%%% !1110 4444 %1W'_'O)_NG^525'<?\>\G^Z?Y4 <U\*_\
MDFGA7_L%VW_HM:ZFN6^%?_)-/"O_ &"[;_T6M=30 4444 %%%% !17.>.5C?
M2]I6&28AO+26[^SC./O9[XX_.N/FOEN])N;FYOK@7=MID$M@7<QN\A5OG"_Q
M,6 !Z_K0!ZG17G-U<E[RXNI+AUUN+4X((H1(01$?+RH3NI5F)./7TKT8].*
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M;/BW_H4X/_!FG_Q- '6T5R7]L^+?^A3@_P#!FG_Q-']L^+?^A3@_\&:?_$T
M=;17)?VSXM_Z%.#_ ,&:?_$T?VSXM_Z%.#_P9I_\30!UM%<E_;/BW_H4X/\
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M]#E=?^ $'_Q-=910!R?_  CWB/\ Z'*Z_P# "#_XFC_A'O$?_0Y77_@!!_\
M$UUE% ')_P#"/>(_^ARNO_ "#_XFC_A'O$?_ $.5U_X 0?\ Q-=910!R?_"/
M>(_^ARNO_ "#_P")H_X1[Q'_ -#E=?\ @!!_\37644 <G_PCWB/_ *'*Z_\
M "#_ .)H_P"$>\1_]#E=?^ $'_Q-=910!R?_  CWB/\ Z'*Z_P# "#_XFC_A
M'O$?_0Y77_@!!_\ $UUE% ')_P#"/>(_^ARNO_ "#_XFC_A'O$?_ $.5U_X
M0?\ Q-=910!R?_"/>(_^ARNO_ "#_P")H_X1[Q'_ -#E=?\ @!!_\37644 <
MG_PCWB/_ *'*Z_\  "#_ .)H_P"$>\1_]#E=?^ $'_Q-=910!R?_  CWB/\
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M)_NG^5 '-?"O_DF?A7_L%VW_ *+6NIKEOA7_ ,DT\*_]@NV_]%K74T %%%%
M!1110 4444 %%%% '*?\U2_[A'_M6NKKE/\ FJ7_ '"/_:M=70 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M -E_WR?\:/\ A7?A+_H V7_?)_QH ZK>O]X?G1O7^\/SKE?^%=^$O^@#9?\
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M$O\ H V7_?)_QH_X5WX2_P"@#9?]\G_&@#JMZ_WA^=&]?[P_.N5_X5WX2_Z
M-E_WR?\ &C_A7?A+_H V7_?)_P : .JWK_>'YT;U_O#\ZY7_ (5WX2_Z -E_
MWR?\:/\ A7?A+_H V7_?)_QH ZK>O]X?G1O7^\/SKE?^%=^$O^@#9?\ ?)_Q
MH_X5WX2_Z -E_P!\G_&@#JMZ_P!X?G1O7^\/SKE?^%=^$O\ H V7_?)_QH_X
M5WX2_P"@#9?]\G_&@#JMZ_WA^=&]?[P_.N5_X5WX2_Z -E_WR?\ &C_A7?A+
M_H V7_?)_P : .JWK_>'YT;U_O#\ZY7_ (5WX2_Z -E_WR?\:/\ A7?A+_H
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M_P"-U$OQ(\.M<M;J^IF=$#M&-*NMP4D@$CR^A(/Y&@#LJ*Y+_A8.A_W=7_\
M!1=?_&Z/^%@Z'_=U?_P477_QN@#K:*Y+_A8.A_W=7_\ !1=?_&Z/^%@Z'_=U
M?_P477_QN@#K:*Y+_A8.A_W=7_\ !1=?_&ZB;XD>'4N([=GU,3R*SI&=*N@S
M 8R0/+Y R,_44 =E17)?\+!T/^[J_P#X*+K_ .-T?\+!T/\ NZO_ ."BZ_\
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M!UM1W'_'O)_NG^5<M_PL'0_[NK_^"BZ_^-TR?X@:&89!MU?[I_YA%UZ?]<Z
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MDR?\M/,R,\C(&#QBJNEZ9)=M;Q6VH17.DV-SOA=HR9D*_P#+,/T91G&?3(H
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MEI"3R6)/X4 6+71K%H=/DDA:62UR\+SG<ZLW))]ZU:** "BBFR,50E5+$#(
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MU.\@TZ)=7ANH+]P;6ZCA \J4*6''1D(##U!Q0!=D\26[WFHK/J/EV[1!;)(
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MZ)=0+;S/<126;1J5<I^]EBV_)&PZ +GMU/-=BJA0 H  X %  B*B!4 55&
M, "EHHH ***Y6XOM4OM<O+"TNXM.EMU#P12P[_M*_P!_.?NYXP.1WH L^)==
MBM+:6&SNHOMJ,OF*N'>*/(WOM[[5.:?IKZ?K-Q<S07,E]&L(MV<,#$01EL8X
M)/&?PK \.Z;?WLHU!)88XI99"VX;GMGWD2JG8AF!PQZ"N[C18UVQJJKZ 8%
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MA6FKF)KCS8Y8N%EA<H^T_>7(_A/<5HPQ)!"D4*JD:*%55&  .@I]% !1110
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Dec. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000947263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TORONTO DOMINION BANK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Dec. 18, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$1,400,000.00</span>. The prospectus is a final prospectus for the related offering.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-25-046175-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-046175-xbrl.zip
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M:Q,E##I!<>_=X-8C/D9ZY5B#?Q7]I :M(%Y1,IERZ#4UJ-AUX18VB1J&GWJ
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MW&E\'K9S83DI[PY;F7FY9M6Y?LUGW[M\7J;?><1G'Q[XYM]02P$"% ,4
M" "D<Y-;9*4=C#@(  !*%P  $               @ $     97AF:6QI;F=F
=965S+FAT;5!+!08      0 ! #X   !F"      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000947263</identifier>
        </entity>
        <period>
            <startDate>2025-12-18</startDate>
            <endDate>2025-12-18</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-32">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-33">TORONTO DOMINION BANK</dei:EntityRegistrantName>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-26">&lt;div style="text-align: center; font-family: Arial; font-size: 12pt;"&gt;The maximum aggregate offering price of the securities to which the prospectus relates is &lt;span style="text-decoration-thickness: initial; float: none; display: inline !important;"&gt;$1,400,000.00&lt;/span&gt;. The prospectus is a final prospectus for the related offering.&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="c0" decimals="2" id="ixv-34" unitRef="usd">1400000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-35">true</ffd:FnlPrspctsFlg>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-38">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-39">0000947263</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-40">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OfferingTableNa contextRef="c0" id="ixv-41">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-42">N/A</ffd:OffsetTableNa>
    <ffd:RegnFileNb contextRef="c0" id="ixv-43">333-283969</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-44">424B2</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
